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Dissertation Defense
PRINTABLE BIODEGRADABLE HYDROGEL FOR SKIN WOUND DRESSING
USING INKJET PRINTING TECHNOLOGY
by
Maria Yanez
Abstract
Chronic wounds are becoming more frequent. Foot ulcers affect approximately 10% 15% of patients with diabetes throughout their lifetimes, and by 2025, it is estimated the
prevalence of diabetes will be 250 million people in the worldwide. There is increased potential
for patients with peripheral neuropathy and peripheral vascular disease to suffer more foot
injuries. These conditions reduce the normal pain sensations and healing of minor traumas,
allowing the development of chronic non-healing ulcers, often preceding lower-extremity
amputation. These types of wounds are very difficult to treat and sometimes take months or even
years to heal because of many possible complications during the process. The treatments of
wounds and its complications represent more than $20 billion in United States, in part because
non-healing wound need repetitive treatments. Close to 10% of patients admitted to hospitals
will receive skin grafting treatments for various reasons, thus bringing the skin grafting market to
$1 billion yearly
Skin graft materials have been used trying to improve wound healing. The majority of
them are allogeneic and they do not survive several days when are implanted. Several studies
exist where commercially available dermal substitutes have been augmented with autologous
cells and these studies suggested that autologous cells still may not survive due to the lack of
vascularization in these constructs. Recognizing this, we have been studying the behavior of
fibroblasts and keratinocytes in engineered capillary-like endothelial networks. A dermoepidermal graft has been implanted in athymic nude mouse model to assess the integration with
the host tissue as well as the wound healing process.
To build these networks into skin graft, a modified inkjet printer was used, which allowed
to deposit human microvascular endothelial cells. Neonatal human dermal fibroblast cells and
neonatal human epidermal keratinocytes were manually mixed in the collagen matrix while
endothelial cells printed. A full thickness wound was created at the top of the back of athymic
nude mice and the area was covered by the bilayer skin graft. The mice of the different groups
(experimental; printable skin graft, comparative; comertial available skin graft-Apligraf®, and
control group; without any type of skin graft) were followed until completion of the specified
experimental time line, at which time the animals were humanely euthanized and tissue samples
were collected. The tissue was fixed in 10% buffer formalin, and process for histological and
immunohestochemical analysis.
In conclusion, wound contraction improved by up to 10% when compared with the
control groups. Histological analysis showed the neoskin having similar appearance than normal
vi

skin. Both layers dermis and epidermis were present with thicknesses resembling normal skin.
Immunohistochemistry analysis showed favorable results proving survival of the implanted cells,
and confocal images showed the human cells location in the samples that were collocated with
the bilayer printed skin graft.
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Executive Summary
Chronic wounds such as diabetic foot ulcer and venous leg ulcer are common problems in
people suffering from type 2 diabetes. These can cause pain, nerve damage, leading to eventual
foot or leg amputation. According to The National Diabetes Information Clearinghouse, 11.3 %
of the US population or 25.6 million people over 20 years old have diagnosed or undiagnosed
diabetes mellitus in 2010 and by 2025, it is estimated that 300 million people will have diabetes.
There is increased potential for patients with peripheral neuropathy and peripheral vascular
disease to suffer more foot injuries. The risk of a diabetic person to develop foot ulcers is 1225%. These conditions reduce the normal pain sensations and healing of minor traumas, allowing
the development of chronic non-healing ulcers, often preceding lower-extremity amputation. The
treatments of wounds and its complications represent more than $20 billion in United States, in
part because non-healing wound need repetitive treatments. Close to 10% of patients admitted to
hospitals will receive skin grafting treatments for various reasons, thus bringing the skin grafting
market to $1 billion yearly.
Skin grafts represent many advantages for treatment for chronic wounds because not only
the wound is protected, but also skin regeneration may be accelerated. There are several dermoepidermal skin graft products, trying to imitate the anatomy of the skin. However, with few
exceptions, these products use allogeneic cells or materials, which do not survive beyond several
days.
In this study a three layer matrix has been investigated. To build 3-dimensional
networked structures, an HP printer was modified allowing to print different bio-inks were cells
viii

can be dispersed. The printable skin graft has three different layers; the top and bottom layers are
made of collagen with neonatal human epidermal keratinocytes, neonatal human dermal
fibroblast cells (NHDF), respectively. Between the two collagen layers resides a thin layer of
fibrin gel with human microvascular endothelial cells (HMVEC). The fibrin layer is obtained by
printing a thrombin solution with HMVEC at the top of a fibrinogen solution.
Collagen type I and Fibrin gel are the main materials in this study. Collagen type I has
been highly used in tissue engineering because it is abundant in live animals and shows good
biocompatibility and slow degradation in the body. Collagen is also used in skin tissue
engineering because it promotes cell attachment and cell proliferation. Fibrin gel might promote
cell proliferation. Fibrin gel is formed by the interaction between thrombin and fibrinogen at
room temperature through an enzymatic polymerization in the presence of calcium ions. It is not
toxic and is biodegraded in the body by the fibrinolytic system. It has been researched as a
scaffold for several tissue engineering applications including of the skin.
The presence of living cells was confirmed with immunofluorescence studies using
different antibodies depending of the cell in study.
Here, we test the integration of the bioprinted skin graft with host tissue in a nude mouse
model. Nude mice have only half of the normal immune system as they lack on the thymus gland
which produces the body’s T-cells and the genetic loci produces a hairless animal. Nude mice
are highly utilized in wound healing research because hair re-growth does not hide the wound
healing process. Athymic nude mouse model provided the opportunity to demonstrate the
scaffolding abilities of the proposed engineered skin and to measure how much the graft
ix

architecture compares to normal skin architecture after healing is complete. In addition, the
athymic nude mouse model will allow to study the integration of the engineered tissue without
interference from immune rejection.
In the current study, a novel printable skin graft was shown to accelerate the wound
healing when it is compared with a commercial available skin wound dressing (Apligraf®), and
without any type of dressing. The transplantation of printable skin graft transfers part of the
artificial in vitro cultivation to the wound area allowing the wound healing. Wound contraction
was improved by up to 10% when compared with the other two groups. Histological analysis
showed the neoskin which is closely related to the normal skin. Immunofluorescence studies
showed the presence of human cells at the fourth week post-surgery.
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Chapter 1

Literature Review

1.1 Skin Anatomy
Skin is the largest organ in our body protecting internal organs from the external
environment while keeping the host free from pathogens. It also maintains body temperature and
hydration (Freinkel & Woodley, 2001). When skin is damaged, its integrity is affected and
internal organs can be exposed to external environment and pathogens. Skin has the ability to
heal naturally (Zhong, Zhang, & Lim, 2010); however, acute wounds require medical
intervention to heal (Boyce & Warden, 2002).
Skin is composed by two main layers, epidermis and dermis as shown in figure 1.1. The
epidermis is the outer layer of the skin. It is the principal barrier to protect from the external
environment, pathogens and dehydration. The epidermis is constantly shedding cells, a process
known as desquamation, and is characterized by new cells pushing up older and dead cells.
Epidermal thickness varies between 75 µm and 600 µm depending on the area. Keratinocytes are
the principal cells of the epidermis as they make up approximately 90-95% of the cells in the
epidermal layer. Keratinocytes main function is to synthesize keratin which provides strength
and mechanical integrity to the skin. Other epidermal cells are melanocytes, which produce
melanin, to provide color to the skin and hair, as well as protection from ultraviolet radiation.
Langerhans cell are part of the adaptive immune system, and Merkell cells detect the sense of
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touch (Penzer & Ersser, 2010; Freinkel & Woodley, 2001); both these cell types are also found
in the epidermis.
Dermis is a layer found between the epidermis and hypodermis or subcutaneous tissue.
The dermis function is to support the epidermis, providing nutrients and oxygen and removing
waste. The junction between dermis and epidermis is very important because it provides
adhesion to both layers, restricts the transit of molecules (by size and charge) and allows the
transit of different type of cells (melanocytes and Langerhans cells). Dermis and epidermis are
connected by a basement membrane which is very important for normal skin function)
(Burgeson & Christiano, 1997). The main proteins of the dermis are collagen, elastin, and
glycosaminoglycans. The majority of this collagen is of type I and it is responsible for
maintaining hydration of the skin, and for providing structural strength to the skin. Elastin is a
protein that helps to maintain flexibility of the skin by forming a fiber matrix that helps the skin
to return to its normal shape after a pull. The dermis contains different types of cells and the
highest concentration can be founded in the papillary dermis and around the blood vessels. The
principal cells in this layer are fibroblast cells which are responsible for the production of
collagen and elastin. Fibroblast cells are also important player in wound healing during the reepithelialization and tissue remodeling. Fibroblast cells migrate into the wound and secrete
collagen, proteoglycans fibronectin, hyaluronic acid along with other proteins which play an
important role in wound contraction and scarring. All of the proteins secreted by fibroblast cells
participate in cellular migration and tissue support. Other cells found within the dermis are mast
cells which are involved in moderating the immune and inflammatory responses. Monocytes,
macrophages and histocytes are also found in the dermis, they form a mononuclear phagocyte
system which is part of the immune system. Furthermore, dermis has many blood vessels, nerve
2

bundles and sensory receptors (Penzer & Ersser, 2010; Freinkel & Woodley, 2001; Zhong,
Zhang, & Lim, 2010).

The average thickness of the Human dermis is 1.35 mm (Hendriks,

Brokken, van Eemeren, Oomens, Baaijens, & Horsten, 2003).
The subcutaneous tissue or hypodermis contains adipose tissue; most of the body fat is
stored in this layer. Some literature does not consider this layer as part of the skin, but it plays a
very important role in insulating the body and absorbing shocks from impact to the skin allowing
the mobility over underlying structures (Freinkel & Woodley, 2001).

Figure 1.1 Structure of human showing the different layers, cells, hair, oil glands, and principal components. This
picture is from the National Cancer Institute Website, and it is not subject to copyright restriction.

1.2 Skin Wounds
According with American Burn Association (ABA), annually in United States
approximately 450,000 people receive medical treatment after burn injuries and the survival rate
is 94.8% (American Burn Association , 2005). Most of deaths caused by burns are due to the
massive fluid losses and the microbial infections (Buddy, Allan, Frederick, & Jack, 2004). These
3

complications are mostly affecting people with second-degree burns, characterized by loss of
epidermis and dermis and third degree burns characterized by damage to all three layers
epidermis, dermis and hypodermis (Buddy, Allan, Frederick, & Jack, 2004).
According to The National Diabetes Information Clearinghouse, 11.3 % of the US
population or 25.6 million people over 20 years old have diagnosed or undiagnosed diabetes
mellitus in 2010. Diabetes treatment accounted for $12 billion in 2007 and the cost to treat this
disease is increasing rapidly (Stevens, 2010). Diabetic foot ulcers are the most common
complication of diabetes mellitus; the risk of a diabetic person to develop foot ulcers is 12-25%.
Diabetes develops foot ulcers because of neuropathy (nerve damage) and/or ischemia (blood
supply restriction), causing insensibility lack of oxygen and glucose, which are essential in cell
metabolism (Cavanag, Lipsky, Bradbury, & Boteck, 2005; Edmonds & Foster, 2006);
neuropathic ulcers being the most common of the two. Neuropathic ulcers general appear in the
plantar surface of the foot, over the heel or over the metatarsal surface. This ulcer starts to form
when the callus becomes thick and it is not removed. The callus then compresses the soft tissue,
causing necropsy. At this point when the callus is removed, ulcer is visible (Edmonds & Foster,
2006). This type of injury is also caused by friction from shoes, cuts, bruises or any other injury
to the foot. The ability of healing wounds depends of many factors: health condition, age, and
habits of patients (Chen, Przyborowski, & Berthiaume, 2009). These types of wounds are very
difficult to treat and sometimes take months or even years to heal because of many possible
complications during the process. Because sometimes there are no adequate treatments for this
type of wounds, in many cases amputation of the foot and sometime even leg is the only
alternative (Armstrong & Lavery, 1998).
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The treatments of wounds and its complications represent more than $20 billion in United
States, in part because non-healing wound need repetitive treatments (Chen, Przyborowski, &
Berthiaume, 2009). Close to 10% of patients admitted to hospitals will receive skin grafting
treatments for various reasons, thus bringing the skin grafting market to $1 billion yearly (Li,
L'Heureux, & Elisseeff, 2011).

1.3 Wound Healing
The wound healing process proceeds along different phases, where each phase involves
interactions between different cell types, blood borne elements, growth factors and the
extracellular matrix (Freinkel & Woodley, 2001). The three main wound healing phases are:
inflammation, proliferation and tissue formation, and tissue remodeling. Each individual has
distinct wound healing process because wound healing requires blood flow and nutrients, so
nutrition is very important during this process. There are other factors that affect wound healing
such as diabetes, cancer, arthritis, infections, smoking, and alcohol (MacKay & Miller, 2003).
1.3.1 Inflammation
This phase initiate after an acute injury. The platelets circulate in the blood and serve to
form a platelet plug over damage vessels and serve three functions; sticking to the injured blood
vessels, attaching to other platelets to enlarge the forming plug, and providing support for the
process of the coagulation cascade. Fibrin gel forms a matrix where keratinocytes start to migrate
and repair the damaged tissue. The inflammatory phase continues with the proliferation of
leukocytes (neutrophils, macrophages), and mast cells. Leucocytes and mast cells help to
eliminate bacteria and eliminate damaged tissue. Neutrophils and macrophages start to generate
growth factor such as fibroblast growth factor (FGF) and cytokines (cell signaling for
5

intercellular communication), stimulating the proliferation of fibroblast cells (Freinkel &
Woodley, 2001; Deonarine, et al., 2007).
1.3.2 Proliferation and tissue formation
A new extracellular matrix and granulation tissue (fibroplasia) start to form in this phase
with the production of collagen, proteoglycans, and fibronectin. Fibroblast cells secret collagen
which substitutes the fibrin matrix that forms during first phase. This phase continues with the
formation of new blood vessels (angiogenesis or neo-vascularization). Angiogenesis starts when
endothelial cells migrate to the fibrin matrix forming new capillaries. This process is very
important because epithelial cells require oxygen and nutrients. During this phase keratinocytes
migrate away from the wound edge for skin reepithealization. The principal cells during this
phase are fibroblasts, endothelial cells and keratinocytes (Freinkel & Woodley, 2001; Deonarine,
et al., 2007; Chen, Przyborowski, & Berthiaume, 2009).
1.3.3 Tissue remodeling
The last phase of wound healing process implicates the reorganization of collagen fibers
to get organized structures, and increase wound tensile strength. This phase is very long taking
months. The principal objective of this phase is to repair the principal barrier (skin) and increase
the tensile strength of the scar (Freinkel & Woodley, 2001; MacKay & Miller, 2003).

1.4 Skin Wound Healing Treatments
Currently, there are different treatments to improve wound healing. Appropriate wound
closure reduces amputation risk, scarring and many complications. The most novel therapies are:
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bone marrow derived stem cells, negative pressure dressing, skin grafting, bioengineered skin
equivalents, and growth-factor therapy.
1.4.1 Bone marrow derived stem cells
Studies have shown that bone marrow (BM) derived stem cell treatment improves wound
healing because BM produces skin cells like fibroblast, keratinocytes, macrophages, fibrocytes
and some other cells that are found in epidermal and dermal layers (Wu, Zhao, & Tredget, 2010;
Fathke, y otros, Contribution of Bone Marrow–Derived Cells to Skin: Collagen Deposition and
Wound Repair, 2004; Badiavas & Falanga, 2003). These cells play an important role in host
defense and during the inflammatory phase during wound healing (Wu, Zhao, & Tredget, 2010).
It also has been shown that the stem cells produced by BM secrete collagen type III and
accelerate the healing process (Fathke, et al., Contribution of Bone Marrow–Derived Cells to
Skin: Collagen Deposition and Wound Repair, 2004). There are studies in human to test the
wound healing process when stem cells are extracted from the BM (iliac crest in humans).
Approximately five minutes after the BM were extracted, it is applied on the wound area
(previously debrided), and injected in the edge of the wound. Patients receive more than one
treatment and for the additional treatments BM cells were culture and washed with saline
solution. The cells were suspended in sodium chloride saline solution and applied on the wound
(Badiavas & Falanga, 2003). There are studies performed in mouse model where the BM is
extracted from the tibia and femur. In this case the cells were washed with phosphate buffered
saline solution and injected in the tail vein (Fathke, et al., Contribution of Bone Marrow–Derived
Cells to Skin: Collagen Deposition and Wound Repair, 2004). BM studies show good results,
however this therapy is not an option when chronic wounds are large. In addition, this treatment
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might not be adequate for elderly people because the bone marrow decreases with age (Chen,
Przyborowski, & Berthiaume, 2009).
1.4.2 Negative pressure dressing
Negative pressure therapy is been used to improve wound healing. This therapy uses the
sub-atmospheric pressure dressing to seal open wounds (Horch, Bleiziffer, & Kneser, Physiology
and Wound Healing, 2012). In this therapy the wound area needs to be clean and disinfected and
the damaged tissue needs to be removed (debridement). The wound is then covered with sterile
non-adherent gauze, and on the top moistened gauzed is applied. Finally, the surface is sealed
with adhesive film and a drained tube is placed in the dressing which is connected to vacuum.
The negative pressure provides wound healing because tissue oxygenation is improved due to the
decrease of liquid in the wound site. Infection is reduced because the negative pressure dressing
is protecting the wound and bacteria are reduced (Horch, Bleiziffer, & Kneser, Physiology and
Wound Healing, 2012). Some studies showed that when a negative pressure therapy was applied
and combined with other methods (hyperbaric oxygen therapy, antibiotic beads, intravenous
antibiotics, alginate dressing, and a bilayer collagen type skin substitute) on different type of
wounds (chronic non-healing foot ulcer, hyperkeratotic plantar lesions, and toe ulcer) observed
wound volume reduction and the formation of granulation tissue (Driver, Ogbonna, Dinnal, &
Powers, 2012). One of the best things in this therapy is that it provides time to the surgeon while
the wound site is improved. There are some studies where the negative pressure therapy was
applied on severe burns and chronic wounds when a keratinocyte fibrin gel suspension was
applied at the top of the injury (Kopp, Jeschke, Bach, Kneser, & Horch, 2004). When negative
pressure was combined with keratinocyte fibrin engraftment, in the most of the cases the
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procedure was applied more than one time and in chronic wound only the 80% wound closure
was observed (Horch, Bleiziffer, & Kneser, Physiology and Wound Healing, 2012). There are
some contraindications in this therapy because extreme care needs to be followed when bleeding
in the wound site. The hemostasis is difficult because the wound debridement or anticoagulant
therapy (Horch, Bleiziffer, & Kneser, Physiology and Wound Healing, 2012). The most of the
cases, this therapy needs to be applied more than two times (it is recommended to change the
dressing at least three times per week), and needs to be combined with other therapies to improve
wound healing (Driver, Ogbonna, Dinnal, & Powers, 2012).
1.4.3 Skin Grafting
Skin grafting in form split or full-thickness skin grafts, tissue flaps and free-tissue
transfers have been the traditional solutions of required skin in patients suffering from chronic
wounds. In split or full-thickness skin grafts, a dermatome is used to collect the full epidermis
and part of the dermis. This layer is placed onto the wound area and sometimes if the wound area
is big, the skin is meshed to cover larger areas. This treatment can be used in healthy people who
do not have any problem with wound healing. However in diabetic patients this treatment cannot
be applied because they lack the ability to regenerate the donor site skin tissue (Chen,
Przyborowski, & Berthiaume, 2009).
1.4.4 Bioengineered skin equivalents
Tissue engineered skin is a therapy that has been studied for more than 25 years to treat
skin injuries (MacNeil, Biomaterials for tissue engineering of skin, 2008). Bioengineered skin
equivalents (BSE) or bioengineered skin substitutes are materials that replace, temporarily or
semi-permanently, the function of the skin. Skin substitutes can be made of different materials,
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natural proteins such as collagen, fibrin, hyaluronic acid or synthetic materials like silicone.
Predominantly, these are porous materials, either cellular or acellular, single layer or bilayer.
Matrix based products
These products are porous matrices of collagen, hyaluronic acid, or fibronectin with the
main function to regenerate skin. These matrices are settled at the top of the skin wound and are
expected to integrate with the host tissue. In some cases when integration with the host tissue is
observed, it is recommended to use an autologous skin graft on top of the acellular matrix. Some
examples of these types of BSE that are currently commercially available are Integra®, and
Alloderm®.
Integra® was developed by Burke and Yannas (Bello, Falabella, & Eaglsteiin, 2001). It
has two different layers the inner layer is bovine collagen with glycosaminoglycan while the
outer layer is a polysiloxane polymer (silicone). This matrix becomes vascularized and it is
necessary to remove the polymer layer and cover it with split thickness skin graft (Bello,
Falabella, & Eaglsteiin, 2001). Integra® is mainly used to treat deep burn injuries, and in some
cases in chronic wound care (Chen, Przyborowski, & Berthiaume, 2009; Integra Life Science
Corporation, 2010; Shevchenko, James, & James, 2010; Lang & Berger, 2000) and it is FDA
approved for both treatments (Li, L'Heureux, & Elisseeff, 2011). The advantages of Integra® is
that it allows the development of new dermis, has a long shelf life, has a low risk of rejection and
disease transmission, and shows reduced wound contraction and scarring (Shevchenko, James, &
James, 2010; Nguyen, Potokar, & Price, 2010). However, this matrix has some disadvantages; it
needs 10-14 days for vascularization, a second operative procedure is required, the collection of
fluid under the matrix might hide infections, and it lacks of an epidermal layer, it is expensive
(Bello, Falabella, & Eaglsteiin, 2001; Shevchenko, James, & James, 2010). Studies performed
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with Integra™ have shown that when Integra™ is supplemented with human keratinocytes, and
applied on a full-thickness wound in athymic mouse model, it was visible the presence of keratin
in the wound site, and histological analysis shows a lower cell density in the matrix, and over the
time the density increases (day 15) (Lang & Berger, 2000).
Alloderm® is a regenerative tissue matrix made of donated decellularized human skin to
avoid immune rejection, and it is lyophilized. The advantages of this matrix are that it is
immunological inert, supplies dermal layer and basement membrane, it allows the use of
autografts (Bello, Falabella, & Eaglsteiin, 2001; Callcut, Schurr, Sloan, & Faucher, 2006). Its
disadvantages are that sometimes it can cause transmission of infectious diseases, presents
uncertain rate of vascularization, and it needs a second operative procedure (Bello, Falabella, &
Eaglsteiin, 2001; Shevchenko, James, & James, 2010).

Alloderm® is mainly used for wound

repair, grafting, and reconstructive surgery. Alloderm® is commonly used for abdominal wall
reconstruction, breast reconstruction, and head and neck reconstruction (Alloderm, 2012; Chen,
Przyborowski, & Berthiaume, 2009). However, it is approved by the FDA only for breast
reconstruction and hernia procedures (Li, L'Heureux, & Elisseeff, 2011). Studies performed in
the University of Wisconsin burn center have shown that when meshed Alloderm® was placed
and overlain with a split-thickness skin graft and applied at the top of different type of injuries
(acute thermal burns, acute traumatic skin loss, chronic non-healing wounds, and severe tissue
loss due to meningococcemia) 100% of the patient with burn injuries had successful re-surfacing
(Callcut, Schurr, Sloan, & Faucher, 2006). These studies demonstrate hyper-pigmentation was
observed in the majority of the cases, hypo-pigmentation 21% and normal pigmentation 16%.
Neo-vascularity was observed in 74% of the cases.
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Cell based products
Many BSE have been trying to imitate skin function by used natural proteins and living
skin cells. They can be monolayer or bilayer grafts, some of them are dermal, epidermal or
dermo-epidermal grafts. Usually, these skin grafts are considered temporary biomaterials due to
the immune rejection. Studies have shown that allogeneic fibroblast may not cause
immunological rejection. However, studies in porcine wound models could not confirm survival
beyond one week (Price, Das-Gupta, Harris, Leigh, & Navsania, 2004) and clinical studies seem
to corroborate those findings (Kolokol'chikova, Budkevich, Bobrovnikov, Baddikova, &
Tumanov, 2001). Allogenic keratinocytes are rejected by the host and may survive a few weeks
at maximum (Shevchenko, James, & James, 2010).
Apligraf® attempts to mimic the structure of the skin by providing with two layers that
are equivalent to epidermis and dermis, containing keratinocytes and fibroblast obtained from
neonatal foreskin (Shevchenko, James, & James, 2010). The bottom layer is composed of bovine
collagen type 1 mixed with fibroblasts. At the top of the collagen is a layer with keratinocytes.
Appligraf® is FDA approved for diabetic foot ulcer and venous leg ulcer treatment. It is supplied
as a circular disk (7.5 cm in diameter per .075 cm thick) and the cost is $1000-1200 per use (see
Figure 1.2) (Apligraft add life to healing, 2010; Morgan & Yarmush, 1997). The cells in this
graft do not survive in vivo, so it is considered a temporal dressing. Some advantages of
Apligraf® are that it is a bilayered skin graft, is available off-the-shelf, and a secondary donor
site is avoided. However, it has only a five day shelf-life, is expensive, is not recommended for a
full thickness wound because it is a temporal dressing, is not easily handle, and may be a source
of disease transmission (Bello, Falabella, & Eaglsteiin, 2001; Shevchenko, James, & James,
2010).
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Figure 1.2. Apligraf® is a bi-layered skin graft dressing with living cells to treat diabetic foot ulcer and leg ulcers.

Dermagraft ® is a bio-absorbable polyglactin mesh with human fibroblasts. Fibroblasts
fill the spaces in the mesh and start to secret collagen and proteins to create a three dimensional
(3D) dermal engineered skin. This graft degrades in 3-4 weeks, and helps in the reconstruction
and remodeling of the dermal layer. The advantages of Dermagraft® are the good resistance to
tearing, easily to handle, and no reported rejection (Bello, Falabella, & Eaglsteiin, 2001). The
disadvantages are that it lacks of the epidermal component, it is expensive, and needs repetitive
applications (Shevchenko, James, & James, 2010). It is approved by the FDA for full-thickness
diabetic foot ulcers treatment. It was found that Dermagraft® can be a temporary or permanent
wound dressing to support a meshed split-thickness skin graft on burn injuries (Halim, Khoo, &
Mohd, 2010).

However clinical trials revealed that when Dermagraft® is combined with a

meshed split-thickness skin graft and applied on full-thickness burn injuries, there is not
observed a significant difference between the application of meshed skin graft and split-thickness
skin graft combined with Dermagraft® (Hansbrough, Doré, & Hansbrough, 1992). There was
also observed no immune rejection to allogeneic fibroblast and very little inflammation It is
supplied in a frozen bag, one piece of 5 cm x 7 cm and the cost is $1,500 per application (see
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Figure 1.3) (Dermagraft Active Livig Cells, 2010; Morgan & Yarmush, 1997; Shevchenko,
James, & James, 2010)

Figure 1.3. Dermagraft is a skin graft dressing to treat full thickness diabetic foot ulcer.

OrCel® is a bilayer dressing which contains neonatal foreskin keratinocytes and
fibroblast seeded into a non-porous collagen type I matrix. Studies have shown that this dressing
induces cytokines and growth factor production (Still, Glat, Silverstein, Griswold, & Mozingo,
2003). It was found studies performed with Orcel® (Still, Glat, Silverstein, Griswold, &
Mozingo, 2003). These studies were performed in patients who presented burn injuries. At the
end of these studies, the results have shown that OrCel® improves wound healing, reduces
scarring, and promotes cell migration, when it was compared with Biobrane (synthetic wound
dressing). However, it is a temporary dressing because it is reabsorbed in 7-14 day (as observed
with Apligraf), and there is not observed cellular DNA from the graft in the wound site at day
14-21 post-application (Shevchenko, James, & James, 2010). Besides, this material lacks of
blood vessels (Shevchenko, James, & James, 2010; Bello, Falabella, & Eaglsteiin, 2001).
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Autologous Products
Currently, there are some skin grafts dressing with autologous cells that promise to be the
next generation of permanent dressing, tough clinical data is not available yet.
Permaderm® is a skin graft that is made with autologous cells. Permaderm® has
fibroblasts and keratinocytes embedded in a collagen layer. This material is intended to be used
in burns. Permaderm® intends to offer a permanent wound closure. This material is not FDA
approved, but the Manufacture is working on a 510(k) clearance (Regenicin, 2011; Kagan,
2007).
Epicel® is an epidermal autograft. It is necessary to take a biopsy of the patient, cultivate
keratinocytes in a feeder layer of 3T3 mouse fibroblast (2-3 weeks). This product is offers a
permanent cover of the wound, and reduces the requirement of donor sites, helps in pain relief,
and promises a better functional and cosmetic effect. The disadvantage is at least 3 weeks are
required to obtain the graft; it lacks the dermal layer and has a high cost. People who have
Epicel® transplants cannot donate blood, any type of tissue, breast milk and sperm because
keratinocytes are harvest onto a feeder layer of 3T3 mouse fibroblast cells and this can a
potential risk of infection to humans. This type of graft is used to treat diabetic foot ulcer, leg
ulcer, burns, pressure ulcers, and other skin injuries (Bello, Falabella, & Eaglsteiin, 2001; Epicel
(culture epidermal autografts), 2012).
1.4.5 Growth factor therapy
Growth factor therapy has been approved for neuropathic wound treatment because this is
the only type of wound it has shown positive results (Goldman, 2004). For this treatment,
polypeptides that bind to different proteins such as TGF-alpha, heparin, or amphiregulin, are
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applied. The polypeptides promote wound healing by stimulating the proliferation and migration
of keratinocytes. According to one study epidermal growth factor helped to improve wound
healing, but the results were not statistical significant (Hardwicke, Schmaljohann, Boyce, &
Thomas, 2008).
There are other treatments to reduce risk of amputation, but they do not increase the
wound healing process. These are hyperbaric oxygen treatment, routine removal of devitalized
tissue and maggot biotherapy, which are effective because they remove necrotic tissue and this
improves the healing process (Cavanag, Lipsky, Bradbury, & Boteck, 2005).

1.5 Inkjet Printing Technology
Inkjet printing is one of the most promising approaches to create complex structures with
soft and low temperature materials suitable for living cells (Hutchings & Martin, 2013). Inkjet
printing is a contactless technique. Ink is ejected out of the nozzle where control amounts of
printed ink can be controlled (Cui & Boland, 2009). Thermal printing involves heating the ink by
a small resistor to create a vapor bubble and eject a drop through the nozzle (Hutchings &
Martin, 2013). With inkjet printing is possible to create lines with thickness in the range of 10100 µm. This technology provides the opportunity to create a temporary matrix where cells can
start to build their own extracellular matrix. Inks designed for inkjet printing are limited to low
viscosity (1-20 mPa). Currently, inkjet printing has been used in biomedical engineering
applications such as drug screening, biosensors and genomics (Boland, Xu, Damon, & Cui,
2006). Cui and Boland created micro-channels when human microvascular endothelial cells were
dispersed in a thrombin solution (bio-ink) and printed onto a fibrinogen solution (bio-paper)
forming fibrin gels with vascular capillary structures (Cui & Boland, 2009). Recently, our group
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has demonstrated that cells can be printed with high viability and biological structures such as
capillaries can be constructed (Tao, Jin, Gregory, Hickman, & Boland, 2005). Different types of
materials have been research to create 3D matrix with different type of cells; thrombin, alginate,
and saline solutions. Our lab has investigated the properties of oxidized alginate to create a
biological ink where fibroblast cells were dispersed and printed onto a gelatin solution forming a
non-thermo reversible gel where cells were immersed (Yanez, Rincon, De Maria, Cortez,
Günther, & Boland, 2012).

1.6 Materials Used
2.6.1 Collagen and gelatin
Collagen is the most abundant protein in animals. It is found in skin, bone, tendon,
cartilage, and ligaments as an extracellular matrix. There are different types of collagen; fibrillar
collagens (I, II, III, and V), fibril-associated collagen (VI and IX) and sheet-forming collagen
(IV) (see appendix 1). Collagen is mainly produced by fibroblast, but epithelial cells are also
known to secrete different types of collagen (I and II) (Lodish, Berk, Zipursky, Matsudaira,
Baltimore, & Darnell, 2004; Hayashi, Ninomiya, Hayashi, Linsenmayer, Olsen, & Trelstad,
1988). Collagen type I is most commonly used as a scaffold for cell-free or cell-base tissue repair
because it is abundant in live animals and shows good biocompatibility (Glowacki & Mizuno,
2007). Collagen needs to be crosslinked to create covalent bonds and increases mechanical
properties. The crosslinked process can be physical such as the ones introduced by UV
irradiation, enzymatic by using transglutaminase as crosslinker for example and/or chemical by
using formaldehyde. Collagen is also used in skin tissue engineering because it promotes cell
attachment and cell proliferation (Parenteau-Bareil, Gauvin, & Berthod, 2010). Collagen
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scaffolds have many applications such as hydrogels in cancer cell migration studies (Li,
Fukunaga-Kalabis, & Herlyn, 2011), bone and cartilage reconstruction, wound treatment
(Parenteau-Bareil, Gauvin, & Berthod, 2010).
1.6.2 Fibrin
During healing process the fibrin gel helps to control bleeding and forms a matrix,
allowing migration and attachment of neutrophils and macrophages to protect the temporary
matrix from infectious agents. It also serves as a temporary scaffold to anchor fibroblasts and
keratinocytes which will remodel and rebuild the injured tissue (Shevchenko, James, & James,
2010; Janmey, Winer, & Weise, 2009). Fibrin gel is formed by the interaction between thrombin
and fibrinogen at room temperature through an enzymatic polymerization in the presence of
calcium ions. It is not toxic and is biodegraded in the body by the fibrinolytic system (Lee &
Mooney, 2001; Janmey, Winer, & Weise, 2009). As stated above, fibrin gel promotes cell
migration and proliferation and because it must be readily available upon injury, fibrin is found
in the blood at very low concentration (Currie, Sharpe, & Martin, 2001) (Yong Lee & Mooney,
2001; Cui & Boland, 2009). It has been researched as a scaffold for several tissue engineering
applications including of the skin (Currie, Sharpe, & Martin, 2001; Lee & Mooney, 2001). In
vivo studies in athymic mouse model revealed a better reconstruction of dermo-epidermal
junction in an induced full-thickness wound when using fibrin-keratinocyte graft (Horch,
Bannasch, Kopp, Andree, & Stark, 1998). Fibrin glue mixed with autologous keratinocytes and
sprayed onto leg ulcer increased wound healing, and this suspension in nude mouse model
increased re-epithelialization (Currie, Martin, Sharpe, & Jamez, 2003).

Fibrin-keratinocyte

matrix in an oral wound rabbit model showed a faster reepithealization (Lis, Zarzecka, Litwin,
Jasek, Cichocki, & Zapala, 2012). Experiments in dog models demonstrated that fibrin reduced
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inflammation in wounds which can be lead to reduce scarring (Currie, Sharpe, & Martin, 2001).
It is as an adhesive in plastic and reconstructive surgery because of those attributes (Janmey,
Winer, & Weise, 2009). It is also used as a dressing or co-culture system for delivery
keratinocytes in burn treatment (Zhong, Zhang, & Lim, 2010). Randomized clinical trials in
patients with acute extensive burn or chronic wounds who were treated with autologous
keratinocytes fibrin gel suspension showed reepithealization (Kopp, Jeschke, Bach, Kneser, &
Horch, 2004). Some disadvantages of fibrin gels might be the immune rejection and infectious
diseases transmission due to the presence of proteins derived from different species from the
recipient (Janmey, Winer, & Weise, 2009).
1.6.4 Cells
It has been shown that the presence of living cells in skin tissue engineering improves
dermal regeneration and wound healing (Still, Glat, Silverstein, Griswold, & Mozingo, 2003;
Callcut, Schurr, Sloan, & Faucher, 2006; Lang & Berger, 2000; Nguyen, Potokar, & Price,
2010). Allogeneic or autologous keratinocytes are widely used in engineered skin equivalents
(Apligraft add life to healing, 2010; Epicel (culture epidermal autografts), 2012; Regenicin,
2011; FortiCell Bioscience, 2008). Animal testing and randomized clinical trials showed that
allogeneic or autologous keratinocytes help to pain relief and accelerated the wound healing
process (Currie, Martin, Sharpe, & Jamez, 2003; Shevchenko, James, & James, 2010). However,
allogeneic keratinocytes cannot survive when are applied onto a wound because of immune
rejection by the host tissue (Shevchenko, James, & James, 2010). The presence of autologous
keratinocytes is required for permanent closure (Blitterswjk, 2008). It is believed that using
autologous keratinocytes might be a good an alternative to improve BSEs because immune
rejection may not occur (Horch, Kopp, Kneser, Beier, & Bach, 2005).
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Fibroblast cells are the principal cells of the dermis. Fibroblast cells not only play an
important role during wound healing, but they also keep skin integrity and youth (Kim, et al.,
2007). During the healing process fibroblast cells migrate to the fibrin gel and proliferate. They
replace the fibrin matrix with a collagen matrix (Freinkel & Woodley, 2001; Kim, et al., 2007).
Fibroblast cells synthesize different growth factors such as keratinocytes growth factor,
endothelial growth factor, insulin growth factor and cytokines that are important for wound
healing (Mazlyzam, Aminuddin, Saim, & Ruszymah, 2008). Fibroblast cells are widely used in
engineered skin equivalents especially those applied on chronic wound or burn wounds
(Apligraft add life to healing, 2010; Dermagraft Active Livig Cells, 2010; FortiCell Bioscience,
2008; Regenicin, 2011). In vitro studies showed that the viability of printed fibroblasts in a
collagen is approximately 95% and there is not observed a significant difference with the control
group (no printed cells). Besides, these studies have shown the cell proliferation over the time
where at day 8 post-printing the highest cell density was observed (Lee, et al., 2009). Studies
performed in pig model revealed that allogeneic fibroblast did not survive more than 7 days
which was also observed in clinical studies when applied onto burn wounds (Shevchenko, James,
& James, 2010).
Endothelial cells are the principal cells to create capillarity. Endothelial cells are present
in all tissue because form small vessels for blood delivery. The presence of this type of cells is
very important because endothelial cells form the inner part of blood vessels, regulate
hemostasis, and they are very important in angiogenesis and vasculogenesis (Sumpio, Riley, &
Dardik, 2002). Moreover, they also produce enzymes, which degrade basal lamina components,
and without this process no re-epithelialization can take place (Blitterswjk, 2008). This type of
cells has been studied to create microvasculature in engineered tissue (Cui & Boland, 2009).
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Studies perform with human dermal microvasculature endothelial cell (HDMVEC) in fibrin or
collagen matrix revealed that HDMVEC begin to form capillary structures in three dimensions
(Bo¨ttcher-Haberzeth, Biedermann, & Reichmann, 2010).

1.7 Statement of the Problem
Approximately 6.5 million patients are affected by chronic wounds such as diabetic foot
ulcers and venous leg ulcers and burn injuries (Sen, y otros, 2010). This problem is increasing as
obesity and diabetes is increasing. About 12-25% patients with diabetes can develop foot ulcers
(Cavanag, Lipsky, Bradbury, & Boteck, 2005). Burns and chronic wounds are very difficult to
treat with treatments taking months and the results often not being very satisfactory. It was found
that the main problems with non-healing diabetic wounds are the progressive degeneration of
nerves, and the blood flow obstruction in lower extremities (Driver, Ogbonna, Dinnal, & Powers,
2012). In addition, chronic wounds and burn injuries reduce the quality of life due to pain,
distress and physical limitations (Velander, et al., 2009). There are many complications in these
types of wounds some of which include nerve damage, blood supply restriction, pain, severe
infections, loss fluid, extremity amputation, or even death (Cavanag, Lipsky, Bradbury, &
Boteck, 2005; Edmonds & Foster, 2006).
Skin graft represents a successful treatment for chronic wounds. The use of grafts
prevents the extremity amputation in 25% of the cases. Bioengineered skin equivalents try to
mimic the physiological function of the skin by replacing its function, and in some cases prevent
infections (Priya, Jungvid, & Kumar, 2008). The use of natural materials such as collagen and
fibrin shows lower toxicity and higher biocompatibility than synthetic materials when they are
applied in skin tissue engineering (Dieckmann, Renner, Milkova, & Simon, 2010). The use of
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skin grafts improves the wound healing process and reduces wound contraction. However, the
existing bioengineered skin grafts still lack of blood supply, nerves, sweat glands, and pigment
(Dieckmann, Renner, Milkova, & Simon, 2010).

These factors limit the integration of the

bioengineered skin graft with the host tissue. In addition, some of the grafts are difficult to
handle, they are not being customizable, and multiple treatments are needed. If it is desired to
create a permanent biodegradable wound dressing, autologous cells must be used to avoid host
rejection (Shevchenko, James, & James, 2010).
Some requirements for tissue engineering of the skin are: wound dressing must need to be
safety, effective, and easily to handle. For these reasons, it is very important to mention that
these biomaterials cannot be toxic, cannot cause immunogenic rejection, and/or inflammation
(Shevchenko, James, & James, 2010; MacNeil, Progress and opportunities for tissue-engineered
skin, 2007). Other features that are important to address are: good biodegradation, able to
support tissue reconstruction, promoting attachment to the wound bed, preventing infection and
fluid loss, ready availability, long shelf-life, promoting vascularization, and improve wound
healing minimizing scarring (Shevchenko, James, & James, 2010; Priya, Jungvid, & Kumar,
2008; MacNeil, Progress and opportunities for tissue-engineered skin, 2007).
Currently, no commercial available engineered skin graft has all the mentioned
requirements, and many only replace one function of the skin temporarily. Most grafts mimic the
protective barrier function of the skin, but other function, like touch, temperature sensation,
excretion, perspiration, thermoregulation, protection from ultraviolet rays, synthetic function,
aesthetic function, are still missing in the existent skin grafts (Shevchenko, James, & James,
2010).
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It was proposed to investigate the capability of inkjet printing technology to fabricate a
novel engineered skin equivalent. In this research, collagen and fibrin gel, natural proteins that
play an important role in wound healing are being used for the fabrication of a skin graft. This
technology is advantageous to current approaches because various cell types can be layered in an
arbitrary shape. An additional advantage is the ability to construct microvasculature structures in
the skin graft when using endothelial cells.

1.8 Proposed Novel Skin Graft
For this research, I proposed to create a bilayer engineered skin graft using inkjet printing
technology. With the creation of this pintable skin graft is intended to alleviate some of the
current problems related with the existing grafts when they are applied in chronic wounds such
as diabetic foot ulcer and venous leg ulcer. This novel graft is a wound cover for chronic
wounds to protect the wound, and promote a better regeneration of the damage tissue by
integration with host tissue something that existing grafts lack. The printable skin graft has
microvasculature, which will supply blood and nutrients to the skin graft. In order to create the
microvasculature, endothelial cells are suspended in a bio-ink (thrombin solution) and printed on
a bio-paper layer (fibrinogen solution), fibrin gel is formed by the interaction of thrombin and
fibrinogen. The printable graft is bilayer because it is composed by an epidermal layer with
keratinocytes and a dermal layer with fibroblast, both layers made of bovine collagen type I. The
printed layer of fibrin with endothelial cells allows me to adhesion of the two collagen layers as
shown schematically in Figure 1.4.
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Figure1.4. Proposed skin model. The top and the bottom layers are made of collagen. The top layer
contains keratinocytes while the bottom layer contains fibroblast cells between these two layers is a fibrin gel layer
with micro-vascular endothelial cells. The fibrin layer was created using an inkjet printer.

The main hypothesis is that the endothelial microvasculature provides better nutrients to
the graft in a nude mouse model. Athymic mice are routinely used in such studies, because they
lack T- cells, and the host tissue will not rejected the different human cells within the graft, thus
allowing the wound healing process to be studied. It has been studied wound contraction, graft
acceptance, epithelial and scar thickness of the grafts compared to two controls; one, a
commercial available skin substitute and two, no graft.
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Chapter 2

Printable cellular scaffold using self-crosslinking agents

2.1 Abstract
The current engineered skin substitutes for diabetic foot ulcer treatment lack effective
host integration. The goal of this research is to create a wound care material that promotes
integration with host tissue. We have been investigating a printable biodegradable scaffold
composed of gelatin and oxidized alginate, both materials with very high biocompatibility and
low toxicity. We investigated the printability of oxidized alginate and its use as an ‘ink’ for dropon-demand crosslinking of gelatin. The oxidized alginate was characterized by Fourier
transform infrared spectrophotometry. Crosslinking rates were investigated as function of
crosslinker concentration. Crosslinking densities were measured by trinitrobenzene sulfonic acid
assay. The mechanical properties of the crosslinked gels were measured in dried samples. The
biocompatibility and ability of the printed scaffolds to support fibroblast attachment and
proliferation was tested. Our results show that using 15% of oxidized alginate and 10% gelatin
allows us to obtain skin wound dressings with better properties.

2.2 Introduction
Tissue engineered skin grafts represent a treatment for chronic wounds such as diabetic
foot ulcers or venous leg ulcers when other treatment options have failed. These types of ulcers
are the most common complication of diabetes mellitus with a prevalence of 8.3% in the US
(Dieckmann, Renner, Milkova, & Simon, 2010). Treatments for chronic wounds and its
complications represent more than 20 billion dollar in the US because these types of wounds
need repetitive treatments (Chen, Przyborowski, & Berthiaume, 2009). Close to 10% of patients
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admitted to hospitals receive skin graft treatments bringing the market for skin grafting to 1
billion dollars per year (Li, L'Heureux, & Elisseeff, 2011).
Current tissue engineered skin grafts have several shortcomings. Acellular grafts need 10
to 14 days for vascularization; they may obscure the infection due to fluid accumulation under
the graft, they can cause immunological rejection, or sometimes they can require a second
procedure (Bello, Falabella, & Eaglsteiin, 2001; Shevchenko, James, & James, 2010). Cellular
grafts suffer from immunological rejection due to allogeneic cells, may be a source of disease
transmission, have short life, are expensive, and difficult to handle (Dermagraft Active Livig
Cells, 2010; Morgan & Yarmush, 1997; Shevchenko, James, & James, 2010).
The main goal of this research is to create a tissue engineered skin graft with better host
tissue integration. We hypothesize that by layering keratinocytes onto a vascularized matrix of
fibroblast cells, the graft resembles the skin structure more closely. We will use inkjet printing to
assemble the graft because it allows to customize the graft, to create complex structure, and to
have homogeneous cell dispersions in the graft.

2.3 Materials and Methods
Alginate, a polysaccharide extracted from algae which has been used extensively as a
material for cell-based therapy, wound dressings, and dental impression (Yong Lee & Mooney,
2001). Gelatin is derived from collagen and it has been used in biomedical application because it
shows high biocompatibility and low toxicity (Young, Wong, Tabata, & Mikos, 2005). Alginic
acid sodium salt (sodium alginate) medium viscosity and sodium periodate ACS reagent grade
were purchased from MP biomedical, gelatin from porcine skin (type A 300 bloom), antibiotic
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antimycotic solution (100X), fetal bovine serum (FBS) were purchased from Sigma Aldrich,
sodium tetraborate decahydrate (Borax) from Fisher scientific, phosphate buffered saline (PBS),
2,4,6-trinitrobenzenesulfonic acid (TNBS), and trypsin-EDTA from thermo scientific, ethyl
alcohol from Pharmco AAPER, and Spectra/Por 6 membrane tubing MWCO 2000 from
Spectrum laboratories. Neonatal human dermal fibroblast cells (NHDF) were donated by Dr.
Karina Arcaute at The University of Texas at El Paso. Dulbecco’s modified eagle medium
(DMEM) high glucose was from Invitrogen.

LIVE/DEAD viability/Citotoxicity kit from

MarkerGene Technologies.
The spectrophotometric measurements were determined by using Perkin Elmer Spectrum
100 series Fourier Transform Infrared Spectrometer (FTIR). Osmolarity analyses were done
using a Fiske Micro-Osmometer Model 210. The absorbance was determined in a Biomate 3
Thermo Scientific Spectrophotometer. During the mechanical testing, a Dynamic Mechanical
Analyzer (DOA 800, TA Instrument, New Castle, DE) was used. For imaging a Nikon Eclipse
Ti microscope and Nikon D-Eclipse C1 confocal unit and software were used.
2.3.1 Alginate oxidation and characterization
Sodium alginate was oxidized in the presence of sodium periodate as described elsewhere
(Yanez, De Maria, Rincon, & Boland, 2011). Briefly, 10 g of sodium alginate were dispersed in
25 ml of ethanol in the presence of 0.4 M sodium periodate, and stirred at room temperature in
the dark for 6 h. Deionized water was added to the solution reaching 1 L, and kept in the dark for
72 h. The precipitate solution was dialyzed until periodate was absent. The oxidized alginate
(OA) was lyophilized.
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The aldehyde group in OA was analyzed in FTIR. The spectra of the samples were
measured using polytetrafluoroethylene sample holder cards in the spectral range between 4000400 cm-1, and analyzing the range 2500-500 cm-1.
Viscosity measurement was carried out in a Brookfield DV-E Digital Viscometer with a
small sample adapter and reticulating ethanol-deionized water solution through the system to
vary the temperature in the testing solution. OA solutions were analyzed when dissolved in PBS
and 0.1M borax solutions varying the spindle velocity, temperature and concentration.
The osmolarity of PBS and 0.1M borax solutions were measured to reduce swelling and
gel deformation (Cui & Boland, 2009).
2.3.2 Scaffold characterization
To measure the gelling time, 0.5 ml of 10% OA in 0.1M borax solution was mixed with
0.5 ml of 10% gelatin in 0.1M borax solution using a magnetic stir bar on a hot plate at 37 °C
and 250 rpm. Gelling time was determined by recording the time elapsed when the stir bar
stopped moving.
The degree of crosslinking was determined by TNBS assay (Balakrishnan &
Jayakrishnan, 2005). In brief, 5 mg OA was reacted with 1ml of 0.5% TNBS and 1ml of 4%
CHNaO3 at 60˚C for 4 h. 1 ml of this solution was reacted with 3 ml of 6N HCl at 40˚C for 1.5 h.
TNBS solution reacts with the unreacted gelatin and forms a soluble solution. The absorbance
(ABS) was measured at 334 nm in a spectrophotometer (Balakrishnan & Jayakrishnan, 2005).
Tensile testing of OA-gelatin scaffold was measured using a dynamic mechanical
analyzer (Instron 5866). Samples (10% OA 10% gelatin) were dried at room temperature. Using
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cardboard strips and cyanoacrylate glue, the rectangular dried samples were placed in the grips
of the Instron. Samples were stretched at room temperature with a constant deformation rate of
0.5 mm∙min-1 until fracture.
2.3.3 Printer modification
An HP Deskjet 340 Printer and HP 33 pens were modified. The HP Deskjet 340 Printer
was modified to control the deposition plate, and the HP 33 pen was modified to print small
sample volume. An aluminum plate was adapted to the printer using the paper feeding sensor and
two switches along the y-axis. Temperature control of the deposition plate is achieved by using a
heat exchange hydraulic system connected in closed loop to a chiller/heater device with a
resolution of 0.1°C (Thermomix/Frigomix 1460/1495, Braun). The geometry of the internal
serpentine of the deposition plate allows the temperature to remain homogeneous with only a
0.4°C maximum difference across the plate in a working range from 4°C up to 90°C. The
deposition plate can be adjusted along the y-axis, using the paper feeding sensor and two
switches. This movement is controlled using a Phidget relay (interfacekit 0/0/8), connected to the
four phases of a PC357XLG half stepper motor. The z-axis is regulated manually with an
adjustable jack allowing to vary the distance between the pen and the plate (see figure 2.1).

Pen holder
Inlet and outlet of
the deposition
plate

Deposition plate
(y-axis)

Phidget relay

Manual z-axis

Figure 2.1 Photograph of the modified HP Deskjet 340 Printer
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2.3.4 Cell maintaining
NHDF were maintained with DMEM supplemented with 10% FBS and 1%
antibiotic/antimycotic solution. Cells were incubated at 37˚C in a 5% CO2 environment. Cells at
passage ten were used in the experiment after 80-90% confluence was reached.
2.3.5 Cell printing
200 µL of 10% OA in 0.1M borax solution mixed with NHDF (1 X 106 cells/ml) and
placed into the modified HP 33 pen. 800 µL of 10% gelatin in 0.1M borax solution was used as
bio-paper on a microscope slide. The biological ink was printed onto the gelatin. Once the cellscaffold was fabricated, it was removed from the glass slide and placed in a sterile petridish with
DMEM. The scaffold was incubated at 37˚C in a 5% CO2 environment. The media was changed
24 hr later and then every other day. Figure 2.2 shows the scaffold obtained by inkjet printing.

Figure 2.2. Photograph of a printed scaffold using a modified HP Deskjet 340 Printer.
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2.3.6 Imaging
Cell viability of the encapsulated cell was tested with LIVE/DEAD assay (LIVE/DEAD
viability/Cytotoxicity kit) at 72 h. Briefly, old media was aspirated and the samples were washed
with PBS to remove remaining DMEM. 20 µL of Ethidium homodimer-1 (EthD-1), and 1 µL of
calcein were diluted in 10 ml of PBS. Samples were place in a 6 multi-well plate and EthD-1calcein-PBS solution was added until the solution was 1 mm level above the scaffold. The
samples were incubated at 37˚C in a 5% CO2 environment for 30 min. The stained gels were
observed using a confocal microscope with fluorescence capabilities.

2.4 Results and Discussion
Sodium alginate is a heteropolysaccharide composed of 4-linked β-mannuronic acid and
its C-5 epimer, α-guluronic acid. The hydroxyl groups of the guluronic acid in the alginate are
oxidized with sodium periodate, by the rupture of the carbon-carbon bond forming aldehyde
groups in each oxidized monomeric unit.
The oxidation of sodium alginate has been previously studied by several groups
(Balakrishnan & Jayakrishnan, 2005; Scoot & Harbinson, 1969; Lu, Zhang, Cao, Lin, Pang, &
Wang, 2009; Huijuan, Zang, & Chen, 2009), and nearly identical reaction conditions were used
in this work.
FTIR spectra of sodium alginate and OA are shown in figure 2.3. The stretching C–O
peak appeared at 1034 cm-1 in both, sodium alginate and OA. The FTIR spectra for OA shows
characteristic peak at 1739 cm-1 for aldehyde group C=O, which is absent in unmodified sodium
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alginate spectra (Lu, Zhang, Cao, Lin, Pang, & Wang, 2009). The aldehyde group of OA makes
possible to crosslink with amino acid group of gelatin, creating a non-thermo reversible gel.

Figure 2.3 FTIR spectrum of sodium alginate (dashed line) and OA (solid line). The characteristic peaks
are labeled.

We also determined the viscosity of 10% OA in PBS at different temperatures (results are
shown in Table I).

The viscosity of 10% OA in PBS is in the range of 25.02-13.2 cP where the

highest is at 25˚C and the lowest at 40˚C. Previous studies have shown that the viscosity range
needs to be between 2-30 cP to obtain a printable ink (Kosmala, Wright, Zhang, & Kirby, 2011).
Thus, it is unlikely to obtain good ink formulations with OA dissolved in PBS because solutions
close to the highest range are more difficult to print. Lower concentrations of OA in PBS could
be used, however the resulting gels will be too weak. Table II shows the viscosity for different
concentrations of OA in 0.1 M borax. The viscosity for OA solution is in the range of 1.2-6.63
cP. For this reason, 0.1M borax solution was employed to dissolve OA and obtain the biological
ink.
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Table I. Viscosity [cP] of 10% OA in PBS at different temperature varying the spindle velocity.
Temperature [˚C]

Spindle Velocity
[rpm]

25

30

35

40

10

20.1

17.7

15.3

13.2

12

20

17.3

14.7

13.2

20

22.9

19.9

17.2

14.9

30

24

20.7

18.2

15.8

50

24.5

21.12

18.54

16.14

60

24.7

21.15

18.65

16.2

100

25.02

21.42

18.93

16.5

Table II. Viscosity [cP] varying the concentration of OA in 0.1M borax solution and the spindle velocity
(temperature remained constant at ~25˚C).
OA Concentration [%]

Spindle Velocity
[rpm]

5

10

15

30

1.2

3.6

5.6

50

1.62

4.14

6.36

60

1.75

4.25

6.35

100

2.13

4.53

6.63

The osmolarity of the ink as well as the substrates were measured to minimize scaffold
deformation (Cui & Boland, 2009). Osmolarity is very important since the mammalian cell
require an isotonicity of 290-310 mOsm to survive. When osmolarity is too high or too low, cell
growth rate decreases and cell death rate increases (Ozturk & Palsson, 1990). The typical
osmolarity range for cells is 260-320 mOsm/kg (Freshney, 2005). The osmolarity for 0.1M borax
solution is 366 mOsm/kg, for PBS solution is 291 mOsm/kg, and for DMEM is 324 mOsm/kg.
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To prevent scaffold deformation and cell death, it will be necessary decrease borax
concentration. The osmolarity was measured for different borax concentration where the optimal
concentration was 0.09M (330 mOsm/kg).
The gelling time was determined for gelatin and OA solutions at different concentrations.
It is observed in figure 2.4 that as the concentration of OA increases (white bar), gelling time
decreases, however the difference in gelling time between 10% and 15% OA in 0.1M borax is
not significant. The gelling time for OA (constant at 10%) dropped from 80 sec to 60 sec when
gelatin concentrations increase from 5% to 10%, but remained constant for higher concentrations
(black bar).

Figure 2.4. Black bar indicates gelling time for OA (10% in 0.1M borax) when the concentration of gelatin
is varied (5%, 10%, and 15%). White bar indicates the gelling time for gelatin (10% in 0.1M borax) when
concentration of OA is varied (5%, 10%, and 15%).

Figure 2.5 shows the degree of crosslinking determined by TNBS assay when OA remain
constant (10% in 0.1m Borax solution) and the concentration of gelatin was varied (5%, 10% and
15%). Crosslink between the amino groups of gelatin and the aldehyde groups of OA is due to
Schiff’s base formation (Balakrishnan & Jayakrishnan, 2005).
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As expected, the degree of

crosslinking decreases when gelatin concentration increases because there are many amino
groups and not enough aldehyde groups to react.

Figure 2.5 Degree of crosslink for 10% OA in 0.1M borax at different gelatin concentrations.

The tensile stress average for dried gels (10% OA with 10% gelatin in 0.1M borax) is
7.12 MPa while ultimate tensile stress average is 5.09 MPa. Previous studies are reported that the
OA improves the mechanical properties of gelatin in rehydrate samples (10% gelatin in distilled
water and 1-3% OA) (Boanini, Rubini, Panzavolta, & Bigi, 2010). Reported tensile stress for
10% gelatin is 2 MPa, and for 10% gelatin with 1% and 3% OA are 2.6 and 2.9 MPa respectively
(Boanini, Rubini, Panzavolta, & Bigi, 2010). The difference between those stresses and the ones
reported here is attributed to the fact that dried samples were used and in previous studies
rehydrated samples were used.
NHDF were encapsulated inside OA-gelatin scaffold by mixing cell with the bio-ink
(10%OA in 0.1M borax) and printing the mixture onto gelatin 36°C ±1°C. Approximately 2
minutes after printing the scaffolds were soaked in DMEM media and placed in the incubator.
Cells in the scaffold were stained with the LIVE/DEAD assay at 72 h, and observed using a
confocal microscope. Figure 2.6 (a) shows the NHDF encapsulated in the scaffold at 72h,
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revealing that cell morphology remains round (adhesion stage). Cell morphology might be due to
the presence of aldehyde group of OA or to the low cell density. Other investigators have found
that fibroblast are alive with regular fibroblast morphology when are seeded onto OA-gelatin
gels (Huijuan, Zang, & Chen, 2009). However, this study did not report fibroblast morphology
when they were encapsulated inside the gel. Figure 2.6 (b) shows confocal images depicting live
cells in strongly green fluorescent calcein (Arcaute, Ochoa, Mann, & Wicker, 2005). The amount
of live cells found in the gels indicates the non-toxic nature of OA-gelatin gels (Balakrishnan &
Jayakrishnan, 2005). Figure 2.7 shows a 10X bright field image of the fibroblast cells in the 10%
OA in borax and 10% gelatin scaffold after 7 days post printing. The characteristic fibroblast
phenotype is seen clearly demonstrating that fibroblast cell attachment between 2 and 7 days of
culture. These data indicate that the gels are non toxic and allow attachment and proliferation of
fibroblast cells.

(b)

(a)

(b)

Figure 2.6 (a) 10X bright field image of NHDF on OA and gelatin scaffold at 72 h, and (b) 10X confocal image of
NHDF.
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Figure 2.7 10X bright field image of the encapsulated cell in 10% OA and 10% gelatin scaffold after 7 days of
culture.

2.5 Conclusions
In summary, oxidized alginate was characterized with respect to printability and it’s
ability to crosslink gelatin. When 0.1M borax solution is used to dissolve gelatin and OA,
biodegradable hydrogels can be created by inkjet printing.

Adding fibroblasts to the OA,

biological ink, allows to construct gels with embedded cells. Cytotoxicity analysis shows the
survival of the cells after printing, and the characteristic fibroblast morphology after the 7 day of
cell encapsulation. Control over the concentration of OA as well as the spatial distribution of the
cells and crosslinkers throughout the scaffold should allow us to create customizable constructs
with improved properties.
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Chapter 3

Fabrication and In Vitro Testing of a Printable Skin Graft to Treat Chronic
Wounds

3.1 Introduction
Tissue engineered skin is a therapy that has been studied for more than 25 years to treat
skin injuries (MacNeil, Biomaterials for tissue engineering of skin, 2008). Bioengineered skin
equivalents (BSE) or bioengineered skin substitutes are materials that replace, temporarily or
semi-permanently, the function of the skin. Skin substitutes can be made of different materials,
natural proteins such as collagen, fibrin, hyaluronic acid or synthetic materials like silicone.
For this study a three layer matrix has been investigated. To build 3-dimensional
networked structures, an HP printer was modified allowing to print different bio-inks were cells
can be dispersed. The printable skin graft has three different layers (figure 3.1); the top and
bottom layers are made of collagen with neonatal human epidermal keratinocytes, neonatal
human dermal fibroblast cells (NHDF), respectively. Between the two collagen layers resides a
thin layer of fibrin gel with human microvascular endothelial cells (HMVEC). The fibrin layer is
obtained by printing a thrombin solution with HMVEC at the top of a fibrinogen solution.
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Collagen with keratinocytes (epidermal layer)
Fibrin gel with endothelial cells
Collagen with fibroblast cells (dermal layer)

Figure 3.1. Squematic representation of the printable skin graft. The top and bottom layers are made of collagen
where keratinocytes and fibroblast cell are dispersed, respectively. The layer between the two collagen layers is a
thin fibrin gel layer with endothelial cells. The small circles represent the channels created by the printing process.

Collagen type I and Fibrin gel are the main materials in this study. Collagen type I has
been highly used in tissue engineering because it is abundant in alive animals and shows good
biocompatibility and slow degradation in the body (Glowacki & Mizuno, 2007). Collagen is also
used in skin tissue engineering because it promotes cell attachment and cell proliferation
(Parenteau-Bareil, Gauvin, & Berthod, 2010). Currently, there are commercial available different
types of dressing (cellular and acellular) to treat chronic wound and burn injuries where the main
matrix is made o collagen (Zhong, Zhang, & Lim, 2010). Some examples of these dressing are:
Integra®, Apligraf®, Dermagraft®, and Orcel® while the only acellular is Integra®. Fibrin gel
might promote cell proliferation (Currie, Sharpe, & Martin, 2001). Fibrin gel is formed by the
interaction between thrombin and fibrinogen at room temperature through an enzymatic
polymerization in the presence of calcium ions. It is not toxic and is biodegraded in the body by
the fibrinolytic system (Lee & Mooney, 2001; Janmey, Winer, & Weise, 2009). It has been
researched as a scaffold for several tissue engineering applications including of the skin (Currie,
Sharpe, & Martin, 2001; Lee & Mooney, 2001). In vivo studies in athymic mouse model
revealed a better reconstruction of dermo-epidermal junction in an induced full-thickness wound
when using fibrin-keratinocyte graft (Horch, Bannasch, Kopp, Andree, & Stark, 1998).
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3.2 Materials and Methods
3.2.1 Inkjet printer modification
A HP Deskjet 340 printer was modified to print different material with biomedical
applications (figure 3.2). The HP DeskJet 340 is a high-quality inkjet printer, giving you a
maximum resolution of 600 x 300 dpi for graphics printing. However, for practical purposes a
300 x 300 dpi were used. The printer was modified to hold a deposition plate (figure 3.3), but the
circuitry from HP was kept to control the printing functions.

Figure 3.2. Modified HP Deskjet 340 Printer
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Figure 3.3. Aluminum plate adapted to the printer using the paper feeding sensor to control the y-axis movement.

Software based on code instructions was used to manage the movement deposition plate
on y-axis, by controlling the printer paper feed. The software was written in Objective-C using
the Cocoa framework, also uses the Phidget library to collect the signal from the printer. Along
the new printer structure there are two switches in certain points of the y-axis limiting the ymovement of the deposition plate. The ink cartridge can be moved along the x-axis, and is
controlled by the original motion system of the HP Deskjet 340. In addition, the deposition plate
was placed onto a manual z-axis to control the distance between the deposition plate and the
cartridge.
In essence, the controllers for the y-axis and the feed paper control are handled by the
interface kit 0/0/8, Phidgets Inc., this interface provides Small Signal Relays with 8 Relay
Outputs, enough to send the signals to the main printer controller in order to limit the y-axis
movement of the deposition plate (figure 3.4). The source code for the InterfaceKit can be
designed in different programming languages such as JAVA, Cocoa, Flash AS3, LabView,
MATLAB, Visual Basic, C# and many others, but some of these programs limit the resources of
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the Phidget relay board. The Phidget21 Installer is the compiler, the software were the user
creates its own instruction code.

Figure 3.4. Phidget interface kit adapted to the 340 Deskjet printer.

The temperature of the aluminum deposition plate is maintained with water circulating
inside a hollow serpentine within the plate. The water is heated or cooled by a
Thermomix/Frigomix 1460/1495 Braun chilled/heater. Thanks to the geometry of the internal
serpentine the temperature on the deposition plate is practically homogeneous (0.4°C maximum
difference) in a working range from 4°C up to 90°C.
For printing, Microsoft Word software was used to create a figure. The figure was a
rectangle 2.5 X 5 cm with a grid inside (distance between lines 1.3 mm).
3.2.2 Cell maintenance
Neonatal human dermal fibroblast (NHDF), human dermal microvascular endothelial
cells (HMVEC), and neonatal human epidermal keratinocytes (NHEK) were purchased from
Lonza, maintained and subcultured according to the manufacturer’s protocol. NHDF were
maintained on Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% Fetal
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Bovine Serum (FBS) and 1% antibiotic/antimycotic solution, HMVEC on Endothelial Growth
Medium (EGM) supplemented with hydrocortisone, human epidermal growth factor (hEGF),
fetal bovine serum (FBS), vascular endothelial growth factor (VEGF), human fibroblast growth
factor-basic (hFGF-B), human recombinant analog of insulin like growth factor-I with the
substitution of Arg for Glu at position 3 (R3-IGF-1), ascorbic acid, heparin and
gentamicin/amphitericin-B. NHEK were maintained with keratinocytes growth media (KGM)
supplemented with bovine pituitary extract (BPE), hEGF, insulin, hydrocortisone, transferrin,
epinephrine, and gentamicin/amphotericin-B. Cells are incubated in at 37˚C in a 5% CO2
environment.
3.2.3 Collagen-fibrin matrix
Collagen type I, bovine cell culture grade (5mg/ml) was from Gibco Invitrogen,
fibrinogen from bovine plasma, thrombin from bovine plasma, phosphate buffered saline (PBS),
10X dulbeco’s modified eagle’s medium (DMEM), 1N NaOH and 4’,6-diamidino-2phenylindole (DAPI) were purchased from Sigma-Aldrich. Fluorescein isothiocyanateconjugated CD34 (BI-3C5; Fluorescein sc-19621 FITC), Alexa fluor 405-conjugated
Citokeratin 5/8 (C50; Alexa fluor 405 sc-8021) and Alexa fluor 647-congugated Fibroblast
Marker (ER-TR7; Alexa Fluor 647 sc-73355) were from Santa Cruz Biotechnologies Inc.
Collagen gel was prepared according with the manufacturers protocol listed in appendix
2, in the protocol is proposed to use 10X PBS or 10X medium 199, but for this specific research
was used 10X DMEM (culture, 2012). Collagens gels were prepared by mixing the appropriate
amount of 10X DMEM, milli-Q water, 1N NaOH and collagen type I. For this research the
concentration of collagen was 3.2 mg/ml. All solutions (10X DMEM, milli-Q water, 1N NaOH
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and collagen type I) were kept in ice until used. In order to obtain the best collagen solution, the
order of mixing is very important. First 10X DMEM, milli-Q water and 1N NaOH need to be
mixed, and at the end (when 10X DMEM, milli-Q water and 1N NaOH are completely mixed)
the collagen solution is added and mixed using a micropipette. Do not make bubbles during the
procedure. Collagen solution was separated in two different sterile falcon 15 ml centrifuge tube
and kept in ice for further used.
The NHDF cells were trypsinized, counted and added the collagen solution previously
separated in a falcon 15 ml centrifuge tube obtaining a final concentration of 2X10 6 cell/ml. 500
µL of collagen-NHDF solution was pipetted on a glass slide and then placed in the incubator at
37˚C with 5% CO2 for 30 min. Gelation was assessed by touching the collagen gel with a sterile
1 ml pipette tip. The collagen gel needs to be firm.
Thrombin was dissolved in 0.08M of CaCl2-PBS solution with a concentration of 40 NIH
units/ml.

Fibrinogen was dissolved in milli-Q water with a concentration of 60mg/ml as

described before (Cui & Boland, 2009). HMVEC cells were trypsinized, counted and the
appropriated concentration of cells was pipetted in a sterile 2 ml micro-centrifuge tube. The cells
were centrifuged, and the supernatant was aspirated. The appropriate amount of thrombin
solution was added to the micro-centrifuge tube to obtain a final concentration of HMVEC of
2X106 cell/ml.
In order to fabricate the sandwich structure shown in figure 1.4, the collagen-NHDF gel
and the glass slide were placed onto the deposition plate of the printer, 250 µL of thrombinHMVEC solution were placed inside of the modified printer cartridge and 200 µL of the
fibrinogen solution were pipetted onto the collagen-NHDF gel. Then, the HUVEC-thrombin
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solution was printed onto the fibrinogen. The glass slide with cellular collagen-fibrin matrix was
placed in the incubator for 10-20 min to allow the fibrin to form.
The NHEK cells were trypsinized, counted and added the collagen solution previously
separated in a falcon 15 ml centrifuge tube obtaining a final concentration of 2X10 6 cell/ml. 200
µL of collagen-NHEK solution were pipetted on top of the fibrin gel and the entire construct was
incubated again for 30 min. The sample was then removed from the glass slide utilizing a pair of
forceps and placed in a 6 cm petri dish with 4 ml of EGM™-2, and incubated at 37˚C with 5% of
CO2 with EGM™-Gold media for 1, 3, 7, 14, 21, and 30 days of culture changing media every
other day. The printed samples were micro-photographed using a Nikon inverted optical
microscope using NIS-Element AR imaging software. The samples were analyzed at different
times (day 3, and day 7 post-printing procedure) using direct immunofluorescence.

3.2.4 Cell viability
Cell viability of the printed HMVECs was tested with LIVE/DEAD assay (LIVE/DEAD
viability/Cytotoxicity kit) at 24 h. Briefly, old media was aspirated and the samples were washed
with PBS to remove remaining DMEM. 20 µL of Ethidium homodimer-1 (EthD-1), and 1 µL of
calcein were diluted in 10 ml of PBS. Samples were place in a 6 multi-well plate and EthD-1calcein-PBS solution was added until the solution was 1 mm level above the scaffold. The
samples were incubated at 37˚C in a 5% CO2 environment for 30 min. The stained gels were
observed using a confocal microscope with fluorescence capabilities.
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3.2.5 Immunofluorescence
For this study, the printed collagen-fibrin scaffolds were fixed with 10% buffer formalin.
the scaffolds were blocked overnight at 4°C in 2% bovine serum albumin and 3% goat serum in
1X PBS. Blocking solution was removed and samples were washed with 1X PBS. The samples
were incubated overnight at 4°C in the dark with the conjugated antibodies (FITC-congugated
CD34, Alexa fluor 405-conjugated Citokeratin 5/8, and Alexa fluor 647-congugated Fibroblast
Marker) in PBS (1:150). The samples were washed with PBS and exposed 300 nM DAPI in
PBS. Samples were incubated at room temperature in the dark for 5 min. Scaffolds were then
rinsed with PBS, and imaged. Confocal images were captured using a Nikon D-Eclipse C1
inverted microscope with a confocal capability with 10X and 20X objectives. DAPI (blue), FITC
(green), Alexa Fluor 405 (red), and Alexa Fluor 647 (red) were exited with laser emitting at 450,
488, and 650 nm wavelengths, respectively.

3.3 Results and Discussion
Figure 3.5-3.7 show the morphology of NHDF, HMVEC and NHEK, respectively at 10X
in invert microscope NIKON NIS-Elements AR 3.1 using phase contrast technique.
The fabrication of the printable skin graft involves the encapsulation of keratinocytes and
fibroblast cells in a collagen matrix while the endothelial cells are embedded in a fibrin matrix
which is generated during the printed process. Photographs of the gels as prepared are shown in
figure 3.8a. The grid pattern printed in the graft is also visible. The printable skin graft is easy to
handle as is shown in figure 3.8b. Figure 3.9a shows the printed channels in the collagen matrix
24 h after the gel was printed. The average of thickness of vertical lines is 218±11µm while in
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the horizontal lines is 363±20 µm. The difference in thickness between vertical and horizontal
lines can be lead to the resolution of the printer which is different in each in x and y axis.

Figure 3.5 Neonatal human dermal fibroblast (NHDF) cell are growing on culture flask. NHDF are
randomly oriented.

Figure 3.6 Human dermal microvascular endothelial cells (HMVEC) are growing on a culture flask.
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Figure 3.7 Neonatal human epidermal keratinocytes (NHEK) are growing on a culture flask. NHEK have a
rhombohedral shape and grow in colonies.

Previous research has shown the structure of a fibrin printed pattern when a Deskjet 500
inkjet printer was used. In this study, the gels kept the shape after printing.
HMVEC were printed, and encapsulated inside of a fibrin gel by mixing thrombin as the
bio-ink and fibrinogen as the bio-paper. Cells in the collagen-fibrin matrix were stained with the
LIVE/DEAD assay at 24 h, and observed using a confocal microscope. Figure 3.10 show the
HMVECs in the printable skin graft after 24h. This picture shows that HMVECs are alive after
the printed process. HMVECs are located in specific locations due to the printed pattern.
Confocal images are shown in Figure 3.11 and Figure 3.12 and show the presence of the
printed cells, which by the day 21 completely filled the printed pattern. The presence of living
cells was confirmed with immunofluorescence studies using different antibodies depending of
the cell in study. Figure 3.11 shows the confocal images of a gel at day 3 after printed. Figure
3.11 a) shows the keratinocytes in the collagen matrix, Figure 3.12 b) shows the printed
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endothelial stained with CD34 and FITC, and the nucleus with DAPI. Figure 3.12 shows the
confocal images of a gel at day 7. In this gel endothelial and fibroblast cells were stained.
Figure 3.12 shows a higher concentration of endothelial cells forming a line, which is the
printed pattern indicated by white arrows. At day 7 the endothelial cells proliferated to a higher
concentration in the printed pattern and migrated out of the printed channel and covered the most
of the gel. However, confocal images do not confirmed the differentiation of endothelial cells
forming tubes.

a)

b)

Figure 3.8 This picture shows the printable skin graft, a) it is observed the printed pattern (small squares), and b) the
graft is held by a forceps.
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Figure 3.9.Both pictures were taken in a Nikon inverted microscope with 10X objective. a) This picture shows the
printed channels using the modified inkjet printer (24h after the gel was printed.

Figure 3.10 This picture shows the HMVECs in the printed skin graft after 24h.

Collagen matrix has been research to asses cell behavior (migration, proliferation, and
differentiation) when are embedded in a collagen matrix (Parenteau-Bareil, Gauvin, & Berthod,
2010). Collagen has been studied to developed different type of engineered skin wound dressing.
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Different types of printer have been research to customize engineered tissue (Cui & Boland,
2009; Lee, et al., 2009; Yanez, Rincon, De Maria, Cortez, Günther, & Boland, 2012). In our lab
a HP Deskjet 340 printer was modified to allow 2D printing (x and y axis) different types of bioinks (with or without cells). In this printing is possible to control the temperature of the
deposition plate (Yanez, Rincon, De Maria, Cortez, Günther, & Boland, 2012). In other studies
inkjet printer are modified to allow printing different types of bio-inks (with or without cells) on
bio-papers (Cui & Boland, 2009). There are other research where has been used a different type
of printer “modular tissue printer platform”. This printer allows to print more viscous solution as
collagen solutions with different type of cells, fibroblast and keratinocytes. Confocal imaging
confirmed the presence of living cells in the different layers (Lee, et al., 2009).
For this research different concentrations of collagen were study to determinate the best
concentration that allowed to handle the gel. The best concentration was 3.2 mg/ml. It was also
found that as increases the concentration of collagen the gel contraction is lower when fibroblasts
cells are embedded in the collagen matrix. This observation was confirmed with studies
performed by Zhu and Rennard team where they found that fibroblast cells contract more the gel
when the concentration of collagen is 0.75 mg/ml than 2 mg/ml (Zhu, y otros, 2001).
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a)

b)

Figure 3.11.Both pictures were taken in a Nikon Eclipse Ti inverted microscope with 20X objective, day 3 after the
gel was printed. a) This picture shows the NHEK stained with Citokeratine 5/8 (red) and the cell’s nuclei stained
with DAPI (blue), and b) shows HMVEC stained with CD34 (green) and the cell’s nuclei stained with DAPI (blue).

Figure 3.12 Pictures were taken in a Nikon Eclipse Ti inverted microscope with 10X objective, day 7 after the gel
was printed. a) shows cell proliferation of NHDF and HMVEC in the collagen-fibrin matrix, b) NHFD were
visualized by staining with a Fibroblast Marker (red), c) HMVEC were visualized by staining with CD34 (green),
and d) cell’s nuclei was visualized by staining the nuclei with DAPI (blue).
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3.4 Conclusions
The main objective of this study was to fabricate a dermo-epidermal skin graft. Skin cells
(keratinocytes and fibroblast cells) were immersed in collagen matrix trying to imitate the
histological appearance of the skin; at the bottom were the fibroblast cells while at the top resides
the keratinocytes. Between the two collagen layers was printed a fibrin gel with endothelial cell.
Immunofluorescence staining confirmed the different type of cells in the cellular matrix.
However confocal images do not confirm endothelial cells differentiation or any tubular
formation.
Inkjet printing technology is a good technique not only to created different types of layers
of engineered tissue. This technique allows to create different types of bio-inks where different
cell types can be dispersed.
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Chapter 4

Printable Skin Graft to Treat Full-Thickness Wounds on Athymic Nude
Mouse Model

4.1 Introduction
Chronic non-healing wounds are becoming more frequent. Foot ulcers affect
approximately 10% - 15% of patients with diabetes throughout their lifetimes, and by 2025, it is
estimated that 250 million people will have diabetes (Boulton, 2000; Driver, Ogbonna, Dinnal, &
Powers, 2012) in the worldwide. There is increased potential for patients with peripheral
neuropathy and peripheral vascular disease to suffer more foot injuries. These conditions reduce
the normal pain sensations and healing of minor traumas, allowing the development of chronic
non-healing ulcers (Lipkin, Chaikof, Isseroff, & Silverstein, 2003), often preceding lowerextremity amputation (when the ulcer becomes infected and gangrenous)(Frykberg, 2002).
One class of devices that has been shown to be somewhat effective in producing better
healing of chronic wounds is tissue-engineered skin substitutes. The concept typically involves
some type of support scaffold or matrix (Langer & Vacanti, 1993). Cells may be combined with
the scaffold at the outset or may populate the scaffold after implantation. In particular engineered
skin substitutes have been explored as a potential application of tissue engineering for over 35
years (Bello, Falabella, & Eaglsteiin, 2001). Most of the available grafts today are allogeneic
products that lack vasculature, which is needed to keep the cells alive, thus all of these products
require multiple applications for chronic wound treatments.
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Recently, bioprinted capillaries have been build and characterized in our laboratory.
Bioprinting refers to the placement of various cell types into a soft scaffold according to a
computer-aided design (cad) template using a single device. We have shown that cells such as
primary keratinocytes, fibroblasts and endothelial cells can be printed onto gels with high
viability rates of above 90% (Bello, Falabella, & Eaglsteiin, 2001). Furthermore, high-density
cell patterns can be generated with this technique. This was possibly because a new bioprinting
system has been designed with the sole purpose to relate the cell concentrations in the printing
cartridges to the amount of live cells per ejected drop (Cui, Dean, & Boland, 2010).
To build the bilayer printable skin graft, a modified inkjet printer was used. This printer
allows to customize the shape and create micro-channels where human microvascular endothelial
cells (HMVEC) allowing the micro-vascular formation. The main materials of the bilayer skin
graft are fibrin gel and bovine collagen type I. Neonatal human dermal fibroblast cells (NHDF)
and neonatal human epidermal keratinocytes (NHEK) are manually mixed in the collagen matrix
while HMVECs are dispersed in a thrombin solution and printed at the top of a fibrinogen layer
forming the fibrin gel.
Here, we test the integration of the bioprinted skin graft with host tissue in a nude mouse
model. Nude mice are highly utilized in wound healing research because hair re-growth does not
hide the wound healing process (Benavides, Oberyszyn, VanBuskirk, Reeve, & Kusewitt, 2009).
The transgenic nature of the mice is that they have only half of the normal animal immune
system as they lack the thymus gland which produces the body’s T-cell, and the genetic loci also
produces a hairless animals. The resultant athymic phenotype mounts no tissue rejection and the
genetic basis of the nude mouse mutation is a disruption of the FOXN (Forkhead box protein N1)
gene which produces the pleiotropic phenotype of hairlessness athymia. Most of the studies that
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have been done in nude mouse create a full thickness wound in the dorsum of the mouse. Mouse
wound healing shows wound contraction close to 90%, which is a significantly different in
human wound healing (Benavides, Oberyszyn, VanBuskirk, Reeve, & Kusewitt, 2009; Li,
Fukunaga-Kalabis, & Herlyn, 2011).
Athymic nude mouse model provided the opportunity to demonstrate the scaffolding
abilities of the proposed engineered skin and to measure how much the graft architecture
compares to normal skin architecture after healing is complete. In addition, the athymic nude
mouse model will allow to study the integration of the engineered tissue without interference
from immune rejection (Laboratory, 2013). The objective of this study is to characterize the in
vivo response to bioprinted skin grafts compared to no graft and the commercially available
Apligraf.

4.2 Experimental
This protocol was approved by the Institutional Animal Care and Use Committee
(IACUC) at The University of Texas at El Paso (UTEP) with the Protocol number A-201109.1.
Sixty male, athymic nude mice (homozygous nude Foxn1nu/Foxn1nu; strain name: J:NU; stock
number: 007850 ) were purchased from The Jackson Laboratory and housed in the animal care
facility located in the Bioscience Research Building on UTEP. The animals were housed under
barrier conditions since the mice have only half of the immune system (athymic) of the normal
animal and cannot mount a normal immune response to pathogens.
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4.2.1 Animal Surgical Procedure
Surgical procedures were performed in the Biosciences A/BSL-1 procedure room. Prior
to any procedure the room was sanitized, and a strict aseptic technique was followed during the
surgical procedure and post-operatative animal care. The day of the surgery, the mice were
anesthetized with intraperitoneal injection (IP) using ketamine(50mg/kg)/xylazine(5-8mg/kg)
and maintained (1-2%) on isoflurane anesthesia using the Veterianary Services portable
anesthesia machine (EZ-Anesthesia Classic Lab Research Anesthesia System). During the
surgical procedure the body temperature of the mouse was monitored using a rectal probe for
mouse.
The animal was surgically prepared for surgery using betadine surgical scub followed by
three times scrubbing the surgical area with 70% ethanol. The animal were injected along the
incision site with 0.5 ml of 25% marcaine, a long-acting local anesthetic and administered
additional analgesia for pain relief by a subcutaneous injection. The animal was placed on a
warmed heating platform to provide additional warming during the surgical procedure.
After ensuring the animal is in a surgical plane of anesthesia the area was covered with a
clear sterile surgical incise drape (3M™ Ioban™ 2 Antimicrobial Incise Drape), which allows
the incision site to be directly viewed as it can be made through the material. An outline of an
approximately 1.7 X 1.7 cm to be excided was marked with a sterile. A full-thickness skin
incision, approx 2mm deep, measuring around 1.7 X 1.7 cm was performed using a #15 scalpel
blade, penetrating down to the subcutaneous tissue. The skin was reflected back and removed.
The wound was approximatly 20-30% of the dorsal of each animal. Bleeding was controlled with
direct pressure on the wound site using a sterile guaze pad, or by using small mosquito hemostats
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on any small vessel bleeding or with a small pen electrocautery unit. Maximum blood loss
allowed was no more than 10%-15% of animals blood volume or approximately 0.3-0.5ml. The
bioprinted skin grafts were placed in the full-thickness wound. For the control group the wound
was either covered with Apligraf®, or not covered by any type of skin graft. The area to be
analized was cover by Mepitel®, a non-adherent silicon dressing to keep the moisture, protect
the wound site and keep the skin graft in place. The Mepitel was sutured using a 4-0 prolene
non-absorbable suture along the edge at 6 different points. A sterile, fine mesh gauze
impregnated with petrolatum (Xeroform®) covered the Mepitel to protect the wound site, and to
maintain a moist wound environment. Xeroform® was sutured on each corner and one suture
between the corners to secure the pad to the animal using a single-4-0 Prolene non-absorbable
suture.
The animal had a post-operative sub-Q injection of 0.1-0.2mg/kg buprenorphine, which
was induced when the animal completely recovered from surgical procedure approximately 20
minutes after surgery. Post-operative analgesia was induced with buprenorphine every 8 hours
(q8) for the first two days if the animal were in pain, then as needed for pain relief.
After the surgical procedure, the animals was placed individually in a cage with sterilized
surgical bedding (diamond chip bedding-Shepard Specialty Paper Co.) and additional warming
was provided during recovery. The animals were continuously monitored during the recovery
period and were placed back into the sterilized individual ventilated cages (IVC) until they were
fully ambulatory and foraging with no overt signs of pain/distress.
The sutured pad was allowed to stay in place for 8-10 days to allow for full healing in the
wound area during which time the animals were monitored at a minimum twice daily for
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pain/distress, self mutilation, infections and surgical pad placement and adequate healing. The
suture pad was removed 8-10 days after surgery.
The mice were followed until completion of the specified experimental time line, at
which time the animals were humanely euthanized and tissue samples were collected. The tissue
was fixed in 10% buffer formalin, and process for histological and immunohestochemical
analysis.
4.2.2 Wound Contraction
Mice were photographed the day of the surgical procedure and at the end point next to a
ruler(Garcia, et al., 2007; Horch, Bannasch, & Stark, 1999). Wound area at each time point was
determined using ImageJ software. The percentage of wound contraction was defined according
with equation 3.1;

Ec. 3.1

4.2.3 Histology
Tissue samples were processed using a Thermo Scientific Spin Tissue Processor Microm
STP-120. The dehydration process was carried out by immersing tissue samples in different
concentration of ethanol (starting with 70%, 95%, 100%), then was followed by the clearing
process where samples were immersed in xylene 3 times, and finally samples were infiltrated in
paraffin. Tissue samples were embedded in paraffin and sectioned with a thickness of 6 µm
using a Shandon Finesse ® E/ME microtome. Tissue samples for immunohistochemistry were
deparaffinized in xylene and hydrated using different concentration of ethanol (100%, 95%, and
70%). Tissue samples were stained with hematoxylin and eosin (H&E) following the protocol
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provided by BCC Histo∙Perfect™ H&E Staining Kit from BCC Biochemical. After the samples
were hydrated, are washed for 30 s in running water, then they are exposed to BCC Harris
hematoxylin fon 3.5 min and rinsed for 1 min with running water and 1 min with BCC acid
Wash•Histo. Right after rinsing the excess of Harris hematoxylin, the samples were immersed in
BCC blueing Solution•Histo for 15 s, then they were rinsed with running water for 1 min
followed by 70% ethanol. Finally, samples were exposed to special Eosin II for 1 min and rinsed
6 times with BBC S2•Histo proceeding by xylene. Samples were mounted with a cover glass and
observed under a microscope to determine the epithelial and scar thickness (Horch, Bannasch, &
Stark, 1999; Wang, et al., 2011; Escamez, et al., 2004). The tissue processing, embedding,
sectioning and staining protocols are listed in Appendices 4-6. Epithelial thickness was
determined using H&E stained cross-sections at the wound margin. Epidermal thickness of the
neoskin was determined by measuring epidermis and dermis thickness of H&E stained crosssections of new skin.
4.2.4 Immunohistochemistry
Tissue sections for Immunohistochemistry (IHC) were deparaffinized in xylene, and
hydrated using successive concentrations of ethanol starting from 100%, 95%, 70%, 50% and
finishing with distilled water. For antigen unmasking, the samples were boiled for 15 min in
antigen retrieval solution consisting of 10 mM sodium citrate, 0.05% Tween 20 at pH 6.0,
cooled on a bench top for 30 min, and rinsed with 1X PBS. Cells were permeabilized with 100%
methanol at -20°C for 6 min to provide access to the antibody. Tissue samples were blocked for
1 h at room temperature in 5% normal goat serum. Samples were incubated for 1 h at room
temperature with mouse monoclonal Anti-Nuclei Antibody, clone 235-1 (GeneTex) in PBS
(1:100). Unbound antibody was removed by washing the samples with three times with PBS 10
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min each. Following, samples were incubated for 1 h at room temperature with Cy™3conjugated AffiniPure Donkey Anti-Mouse IgG (Jackson ImmunoResearch Laboratories) in PBS
(1:500). The samples were rinsed as before, and during the final rinse, the cells were incubated
with DAPI. Samples were mounted with DAKO mounting media (DAKO Corp.) and covered
with a coverslip. Imaging was performed with a LSM 700 Zeiss microscope with confocal
capabilities using a 20X objective, and assisted with ZEN 2009 software.

4.3 Results and Discussion
4.3.1 Macroscopic observations
Following transplantation, the printable skin grafts were initially viable pink and soft
while meshed Apligraf® were white. Figure 4.1 shows the grafting procedure at different time
points. Figure 4.1 a) shows the marked area, and b) shows the full thickness wound. Figure 4.1 c)
and d) show the application of the engineered skin; in c) the printed skin graft is shown, while in
d) a meshed Apligraf® is shown. The wound with or without the graft is covered by Mepitel® as
shown in (e) and by the xeroform® as shown in (f). Day 7 after the surgical procedure Apligraf®
looked yellow, and by day 14 Apligraf® dried out and visibly detached from the wound site
(figure 4.2 a), and

while the printed skin grafts adhered to the wound tissue (figure 4.2 b). 5

mice presented white protuberances in the wound site when Apligraf® was applied (figure 4.2 c)
while in the other two groups white protuberances remained absent. No infection was observed
over the time in any of the groups. The mice with printed skin graft healed by the beginning at
the third week or full closure were achieved sometimes between 14-16 days. The mice in the
control group healed at the end of the third week or 21 days. Finally, the mice with the
Apligraf® healed at the end of the fourth week or 28 days, and in 3 cases the wound was not
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completely closed at the end of the fourth week, which was the latest endpoint studied. Previous
studies have shown that composite epidermal skin grafts healed approximately one week faster
than control mice in a comparable experimental setup (Kuikui, et al., 2006). Clinical data
revealed that Apligraf® may degrade partially or completely after the initial application (Human
Skin Equivalent (HSE) , Apligraf® Part II Clinical Use) and in 3-5 days may have a appearance
to yellow gelatin (Masseth, 2002). Here was mentioned that when it is required to change the
dressing sometimes the Apligraft® is pulled off because it is partially adhered to the dressing
(Masseth, 2002).
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a)

b)

c)

d)

e)

f)

Figure 4.1. Surgical procedure at different time points showing the full thickness wound and graft procedures. a) the
area is marked with a standardized template, b) the full thickness wound is documented, c) the printed skin graft is
applied, d) the Apligraf® is applied e) the Mepitel® is sutured in six different points, and f) the Xeroform® is
applied helping to maintain moisture in the wound site.
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b)

a)

c)

Figure 4.2. a) shows how the Apligraf® completely dried at the top of the created wound at post operative week 4,
b) shows the regenerated skin when a printed skin graft was applied in the wound site at post operative week 6, and
c) shows a white protuberance at the top of the created wound at post operative week 6.

4.3.2 Wound Contraction
Results of the wound contraction are shown in figure 4.3. The percentages of wound
contraction with respect to the wound on day 0, in the group with the printable skin graft were
69±4%, 71±2.4%, 66±9%, 68±4.4%, and 62.5±9 % at week 2, 3, 4, 5, and 6 respectively. The
wound contraction slightly decreases over the time. This could be related to tissue remodeling of
the scar which starts to looks normal tissue. Contraction is a normal process during wound
healing, however when the contraction is a deficiency during wound healing (Diegelmann &
Evans, 2003). Remodeling is when the collagen fibers re-accommodate and the injured tissue
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start to look similar to non-injured tissue (Diegelmann & Evans, 2003). In other studies, the
contraction was approximately 64% after 6 weeks post graft (Kalyanaraman & Boyce, 2009). In
the Apligraf® graft, and the control group the wound contraction was larger than in the printed
skin graft group; 12% when it is compared with the Apligraf® group and 10% when it is
compared with the control group . The percentage of wound contraction in the comparative
group with the commercial skin graft was 80±2.3%, 79±5% at week 4 and 6, respectively. It was
not impossible to calculate the percentage of wound contraction at weeks 2 and 3 of for mice,
because the wound had not closed completely. The percentages in wound contraction after week
5 for the control group were 75±7%, 79±4.7%, and 79±2%. In the control group the percentage
of the wound contraction slightly increases over the time, as do those in the commercial skin
graft. It was found in previous research that the peak of wound contraction was between the
second and third week (Kalyanaraman & Boyce, 2009; Boyce, Supp, Swope, & Warden, 2002)
It was observed that the first two weeks post-surgery the wound significantly contracts
(69% for the printable skin graft group and 75% for the control group). Wound contraction is not
part of the healing process; however, it is the primary process where the wound area is reduced
over the time where the highest contraction is observed between the first and the second week
(Hazel, 1999). The cells responsible for the wound contraction are fibroblast and myofibroblast
cells which migrate from the wound boundary to the wound; the migration deforms the
extracellular matrix causing the wound contraction (Tranquillo & Murray, 1993; Mulvaney &
Harrington).
The studies reported here are consistent with the previous studies done by Kalyanaraman
& Boyce who fabricated an engineered skin substitute (ESS) using a Kerator bioreactor
(Kalyanaraman & Boyce, 2009). The ESS was composed by an epidermal layer with autologous
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keratinocytes attached to a bovine collagen matrix with autologous fibroblast cells (dermal
layer). The ESS was implanted in athymic mice where the wound contraction was evaluated
obtaining approximately 65% wound contraction (Kalyanaraman & Boyce, 2009). Other studies
performed with athymic mouse model revealed that when keratinocytes and fibroblast cells are
seeded onto an acellular collagen-glycosaminoglycan matrix augmented with vitamin C is
implanted on a full-thickness wound, the wound contraction is approximately 70% at week 6
(Boyce, Supp, Swope, & Warden, 2002).

Wound Contraction

Percentage [%]

90

80
Printable skin graft

70

Commercial skin graft

Control

60

50
2

3

4
Week

5

6

Figure 4.3. The graph is showing the wound contraction in the experimental groups (printable skin graft and
commercial skin graft, Apligraf®), and in the control group at the end point of each group between week 2 through
the week 6 (n=5).
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4.3.3 Histology
Based on H&E staining of the different groups during animal testing, the morphology of
the new skin is closely similar to the mouse skin as shown in figures 4.4-4.6. Wound covered by
Apligraft material showed layers, epidermis and dermis. The same results are observed in the
control group. The wounds covered by the printable skin grafts presented almost the same
thickness for both dermal and epidermal layers as the normal mouse skin. The only difference is
that in normal mouse skin shows sebaceous glands, some hair follicles, and hair bulbs. In some
of the samples with the printed skin there is some evidence of blood vessels as marked by green
arrows in figure 4.7. This formation was observed in 2 week samples and is interpreted to be due
to printed HMVECs in the graft. Studies performed by Lang and Berger revealed that when
Integra® is seeded with keratinocytes and implanted on a full-thickness wound, the matrix
infiltrate in the wound bed. H&E staining revealed that after 8 weeks post-surgery the epidermis
has developed (Lang & Berger, 2000). Other studies have shown that when a collagen matrix
with skin cells (keratinocytes and fibroblast cells) is implanted on a full-thickness wound, the
epidermal and dermal layer are present in the neoskin (Boyce, Supp, Swope, & Warden, 2002;
Kempf, y otros, 2011; Kalyanaraman & Boyce, 2009).
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Figure 4.4. 10X micrograph taken at week 4 after the commercial skin graft was applied.

Figure 4.5. 10X micrograph taken at week 4 after of the control group.

Figure 4.6. 10X micrograph taken at week 5 after the printable skin graft was applied. Yellow line indicates the
boundary between the old and new skin; at the left side is the old skin while in the right side is the new skin.
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a)

b)

Figure 4.7. a) 10X micrograph taken at week 2 after the printable skin graft was applied. Green arrows indicate the
small micro channels found in the new skin, b) is a 20X micrograph of the marked area in a).

Epidermal thickness
At the week 6 the total epidermal thickness (epidermal + dermal layers) was 239±35 µm
in the printed skin graft group, 289±190 µm in the Apligraf group, whereas 208±73 µm for the
control group without graft week 6 post-surgery. In the Apligraf group is a high standard
deviation because it was found in our experimental studies that the mouse skin is irregular in
thickness, and then one mouse in this group presented a thicker dermal layer than the other mice
in this group. There is not a significant difference between the three different groups (figure 4.8).
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Figure 4.8. This graph is showing the epidermal thickness in the experimental groups (printable skin graft and
commercial skin graft, Apligraf®), and in the control group at week 6.

Epithelial thickness
The mean of the epithelial thickness was 29.7±4.2 µm for the printed skin graft group,
16.8±8 µm in the Apligraf skin graft group, whereas 21.5±7.6 µm for the control group without
graft after week 6 post-surgery. The mean for the epithelial thickness in the printable skin graft
group is thicker than in the commercial skin graft and the control group. However, this
difference is only significant at 0.05 (Figure 4.9). Epidermal thickness of the mouse skin
(without any treatment or wound) was 32.07±4 µm. That means that approximately 92%, 53%
67% of the epidermal layer regenerate in the printable skin graft, Apligraf, and control groups,
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respectively. Excision wounds were created in athymic nude mouse and the healing process was
monitored by studying epidermal histology. Histological analysis revealed that all major features
of the skin wound healing (dermis, and epidermis) accurately recapitulated in mouse with the
printable skin graft implantation.
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Figure 4.9.This graph is showing the epithelial thickness in the experimental groups (printable skin graft and
commercial skin graft, Apligraf®), and in the control group at week 6.

4.3.4 Immunohistochemistry
For immunohistochemistry was selected an Anti-Nuclei Antibody, clone 235-1 that
stains the nuclei of human cell type giving a nuclear staining patter, and visualize with a Cy™ 3conjugated AffiniPure Donkey Anti-Mouse IgG (H+L). A HMVEC positive control was used to
test the affinity of the selected antibody to our cell line. Figure 4.10 shows the positive control
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when HMVECs were stained with DAPI used to confirm presence of the antibody in the same
cell. For the negative control native mouse skin was used, and results shown in figure 4.11. This
figure also shows the nucleus of the cells that were stained with DAPI, and no human cells are
observed, however some background staining is seen. Figure 4.12 and 4.13 show the
immunohistochemistry staining for the mouse skin with a printed skin graft at week 2, and week
6 post-surgery, respectively. These figures show the presence of human cells in the mouse
dermis implying that the neoskin was regenerated with the human cells within the printable skin
graft. However, there is observed that at week 2 the density of human cells in the mouse skin is
higher than the density of cells at week 6. This is due might be due to the immune rejection of
the athymic nude mice. The transgenic nature of the mice is that they have only half of the
normal animal immune system as they lack the thymus gland which produces the body’s T-cell,
and the genetic loci also produces a hairless animals.

Figure 4.14 shows the

immunohistochemistry staining for the mouse skin when was implanted the commercial skin
graft (Apligraf®) at week 4. In this image the density of human cells is very low.

80

Figure 4.10.Immunohistochemistry staining (positive control). Confocal image with a 20X objective, HMVECs
were stained with Anti-Nuclei Antibody, Clone 235-1, and visualized with Cy™ 3 conjugated AffiniPure Donkey
Anti-Mouse IgG (H+L) (red). The nuclei of the cells also were stained with DAPI (blue).

Figure 4.11.Immunohistochemistry staining (negative control). Confocal image with a 20X objective, skin mouse
was stained with Anti-Nuclei Antibody, Clone 235-1, and visualized with Cy™ 3 conjugated AffiniPure Donkey
Anti-Mouse IgG (H+L) (red). The nuclei of the cells also were stained with DAPI (blue).
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Figure 4.12.Immunohistochemistry staining (printable skin graft). Confocal image with a 20X objective, skin
mouse with the printable skin graft after at week 2 was stained with Anti-Nuclei Antibody, Clone 235-1, and
visualized with Cy™ 3 conjugated AffiniPure Donkey Anti-Mouse IgG (H+L) (red). The nuclei of the cells also
were stained with DAPI (blue).

Figure 4.13.Immunohistochemistry staining (printable skin graft). Confocal image with a 20X objective, skin
mouse with the printable skin graft after at week 6 was stained with Anti-Nuclei Antibody, Clone 235-1, and
visualized with Cy™ 3 conjugated AffiniPure Donkey Anti-Mouse IgG (H+L) (red). The nuclei of the cells also
were stained with DAPI (blue).
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Figure 4.14.Immunohistochemistry staining (commercial skin graft, Apligraf®). Confocal image with a 20X
objective, skin mouse with the printable skin graft after at week 4 was stained with Anti-Nuclei Antibody, Clone
235-1, and visualized with Cy™ 3 conjugated AffiniPure Donkey Anti-Mouse IgG (H+L) (red). The nuclei of the
cells also were stained with DAPI (blue).

Although the fibrin gel described above does not mimic the normal human extracellular
matrix of skin, it is a temporary, blood-clotting matrix that forms in wounds that eventually will
be replaced by other extracellular matrix proteins as the wound heals. We would test this
hypothesis by quantifying the wound healing and comparing it to the healing of a commercially
available skin construct. From the results obtained here it is evident that the matrix was replaced
by a matrix that approximates normal skin within 2-3 weeks post implantation. The replaced
tissue resembled native tissue in many respects such as thickness of both epidermal and dermal
layers, structure of both layers are normal and cell content, except lacking glands and hair
follicles. In the epidermal layer is also observed a normal keratin in the stratum corneum.
Keratinocytes were found in the epidermal layer with a normal shape. In the dermal layer was
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not found any sign of inflammation, and the in this layer were found blood vessels. In these
tissue samples were not possible to detect collagen filament, and the hypodermis, or
subcutaneous tissue was destroyed when the samples the exposed to xylene. It is evident from
the H&E staining that the remodeled tissue is more normal than scar tissue.
There is clearly room for improvement in existing skin grafts, and adding endothelial
cells to a network is a big step in the right direction. There is some evidence that the addition of
endothelial vessel networks will achieved viable integration. One possibility of how those
vessels will integrate with neighboring vasculature or support viability in vivo is possibly by the
same mechanism that are involved in full thickness grafts or cadaver grafts integration. These
processes are not completely understood and depend on the type of graft (full thickness vs. split
thickness), the wound bed preparation and nature of the inflammatory response of the host.
While we have not delineated all these effects here, we did establish that the presence of
endothelial networks throughout the graft will improve the existing graft take over the
commercial product that lacked those networks.

4.4 Conclusions
In the current study, a novel printable skin graft was shown to accelerate the wound
healing when it is compared with a commercial available skin wound dressing (Apligraf®), and
without any type of dressing. The transplantation of printable skin graft transfers part of the
artificial in vitro cultivation to the wound area allowing the wound healing. Wound contraction
was improved by up to 10% when compared with the other two groups. Histological analysis
showed the neoskin which is closely related to the normal skin. Immunofluorescence studies
showed the presence of human cells at the fourth week post-surgery.
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Chapter 5

Conclusions
This research was focused on using inkjet printing technology, and natural proteins,
collagen, fibrinogen and thrombin, to create a bilayer scaffold with applications in tissue
engineering. The main objective of this research was to create a printable skin wound dressing
for regeneration of chronic wounds, diabetic foot ulcers and venous leg ulcers.
The appropriate conditions when collagen was neutralized, allowed the top and bottom
layer of the scaffold. The interaction of thrombin and fibrinogen, created the fibrin gel which had
specific channels for cell proliferation. A modified inkjet printer 340 allowed the creation of the
channels with the scaffold.
Different types of cells where used to mimic the histological appearance of the skin. The
proposed skin graft had epidermal and dermal layer. The epidermal layer was enriched with
keratinocytes and dermal layer was enriched with fibroblast cells. Between these two layers was
printed a fibrin layer with endothelial which allowed the formation of different micro-channels.
Animal testing allowed to test the printable skin graft on athymic mouse model, and
compared with a commercial material to study the integration with the host tissue as well wound
healing. Wound contraction showed a lower wound contraction in the testing group with the
printable skin graft than the commercial material and the control group. Histological analysis
showed the neoskin which is closely related to the normal skin. There is not a significant
different between the different groups. Immunohistochemistry showed the presence of human
87

cells in the neoskin at week 4 when a printable skin graft was applied on a full-thickness wound.
This means that the printable skin graft help to regenerate the tissue and the human cells migrate
to the neoskin. Over the time the human cells in the new skin decrease and at week 6 human cells
were not observe within the neoskin.
For future research on skin wound dressing, mouse provides very interesting information
about the wound healing. However there is necessary to test skin grafts in an animal model like
pig model due to their close resemblance of their skin, integument and physiology is to humans.
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Appendix

Appendix 1. Major Collagen Molecules
Type
Fibrillar Collagens

Molecule Composition

Structural Features

Representative Tissues

I

[α1(I)]2[α2(I)]

300-nm-long fibrils

II

[α1(II)]3

300-nm-long fibrils

III

[α1(III)]3

300-nm-long fibrils; often
with type I

Skin, muscle, blood vessels

V

[α1(V)]3

390-nm-long fibrils with
globular N-terminal
domain; often with type I

Similar to type I; also cell
cultures, fetal tissues

[α1(VI)][α2(VI)]

Lateral association with
type I; periodic globular
domains

Most interstitial tissues

IX

[α1(IX)][α2(IX)][α3(IX)]

Lateral association with
type II; N-terminal globular
domain; bound
glycosaminoglycan

Cartilage, vitreous humor;

Sheet-Forming Collagens
IV

[α1(IV)]2[α2(IV)]

Two-dimensional network

All basal laminaes

Skin, tendon, bone,
ligaments, dentin,
interstitial tissues
Cartilage, vitreous humor

Fibril-Associated
Collagens
VI

SOURCE: K. Kuhn, 1987, in R. Mayne and R. Burgeson, eds., Structure and Function of Collagen Types,
Academic Press, p. 2; M. van der Rest and R. Garrone, 1991, FASEB J. 5:2814.
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Appendix 2. GIBCO Invitrogel protocol to prepare collagen type I gel.
1. Collagen, 10X MDEM, milli-Q water and 1N NaOH need to be on ice.
2. Calculate the concentration and volume of collagen needed with the equation 2

Eq. 2

3. Calculate the concentration of the different solution to neutralize the collagen ( milli-Q
water, 1 N NaOH and 10X MDEM) with the next equations (eq 3-5):

Eq. 3

Eq. 4

Eq. 5
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Appendix 3. Experimental time line for animal testing

1

Groups

C1
C2
C3
TM1
TM2
TM3
TM4
TM5
EM1
EM2

Week
3

2

4

5

5
5
5
5
5
5
5
5
5
5

EM3

5

Each group is composed by 5 mice. Control group (C), testing material (TM) and existing
material (EM).
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Appendix 4. Tissue Processing
Tissue processing is a common technique used in histology. The main objective of this
process is to dehydrate the tissue. Tissue processing has different steps (dehydration, clearing,
and infiltration) and for this specific research the collected tissue was processed according to the
next process using an automatic spin tissue processor (Thermo Scientific Spin Tissue Processor
Microm STP-120). After the tissue was process, samples were embedded in paraffin and slice
using a microtome.

Step

Solution

1
2
3
4
5
6
7
8
9
10

70% Ethanol
95% Ethanol
100% Ethanol
100% Ethanol
100% Ethanol
Xylene
Xylene
Xylene
Paraffin
Paraffin

Time
[min]
5
10
5
10
15
5
10
10
60
75
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Temperature
[°C]
25
25
25
25
25
25
25
25
60
60

Stirring rate
[RPM]
60
60
60
60
60
60
60
60
60
60

Appendix 5. Hematoxylin and eosin staining protocol
For this protocol was used the BCC Histo∙Perfect™ H&E Staining Kit from BCC
Biochemical. To stain mouse skin was followed the protocol provided by BCC Biochemical with
slightly modifications. For this procedure was used a bench-top slide stainer; The Shandon
Varistain Gemini ES from Thermo Scientific.
Step
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24

Solution
100% Ethanol
100% Ethanol
95% Ethanol
95% Ethanol
70% Ethanol
Running H2O Wash
BBC Harris Hematoxylin
Running H2O Wash
BBC Acid Wash•Histo™
Running H2O Wash
BBC Blueing Solution•Histo™
Running H2O Wash
70% Alcohol
BBC Special Eosin II™
BBC S2•Histo™
BBC S2•Histo™
BBC S2•Histo™
BBC S2•Histo™
BBC S2•Histo™
BBC S2•Histo™
Xylene
Xylene
Xylene
Mount and coverslip
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Time
20 seconds
20 seconds
20 seconds
20 seconds
20 seconds
30 seconds
3.5 minutes
1 minute
1 minute
1 minute
15 seconds
1 minute
30 seconds
1 minute
20 seconds
20 seconds
20 seconds
20 seconds
20 seconds
20 seconds
20 seconds
30 seconds
30 seconds
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